The value of the Voice Handicap Index-questionnaire and acoustic analyses to the laryngological examination. by Karlsen, Tom
Tom Karlsen
The value of the Voice Handicap
Index-questionnaire and acoustic
analyses to the laryngological
examination.
2020
Thesis for the degree of Philosophiae Doctor (PhD)
University of Bergen, Norway
at the University of Bergen
Avhandling for graden philosophiae doctor (ph.d )
ved Universitetet i ergen
.
2017
Dato for disputas: 1111
Tom Karlsen
The value of the Voice Handicap Index-
questionnaire and acoustic analyses to
the laryngological examination.
Thesis for the de ree of P il i  Doctor (PhD)
Date of defense: 23.09.2020
The material in this publication is covered by the provisions of the Copyright Act.
Print:     Skipnes Kommunikasjon / University of Bergen
© Copyright Tom Karlsen
Name:        Tom Karlsen
Title: The value of the Voice Handicap Index-questionnaire and acoustic analyses to the
laryngological examination.




1. CONTENTS .............................................................................................. 3 
2. SCIENTIFIC ENVIRONMENT ............................................................ 5 
3. ACKNOWLEDGEMENTS ..................................................................... 6 
4. ABBRAVIATIONS .................................................................................. 8 
5. SUMMARY ............................................................................................ 11 
6. LIST OF PUBLICATIONS ................................................................... 14 
7. INTRODUCTION .................................................................................. 15 
7.1 THE VOICE ......................................................................................... 15 
7.2 EXAMINATION AND EVALUATION OF VOICE-RELATED 
SYMPTOMS ................................................................................................ 16 
7.2.1 Video-laryngo-stroboscopy .......................................................... 18 
7.2.2 Assessment of voice quality by listening to the voice ................... 18 
7.2.3 Acoustic analyses ......................................................................... 21 
7.2.4 Aerodynamic examination - maximum phonation time ............... 24 
7.2.5 Patient-reported outcome measures (PROM) ............................. 24 
7.3 QUALITY OF LIFE .................................................................................. 27 
7.3.1 Quality of life term ....................................................................... 27 
7.3.2 General Quality of Life Measures ................................................ 29 
7.3.3 Symptom-specific Quality of life Measures .................................. 30 
 4
7.4 THE PERSONALITY ASPECT .................................................................. 31 
7.5 VOICE DISORDERS ................................................................................ 35 
7.5.1 Organic voice disorders ............................................................... 36 
7.5.2 Functional voice disorders .......................................................... 41 
8. AIMS OF PRESENT STUDIES ........................................................... 43 
9. STUDY DESIGN, SUBJECTS AND METHODOLOGY ................. 44 
9.1 DESIGN ................................................................................................. 44 
9.2 ETICHS .................................................................................................. 44 
9.3 SUBJECTS .............................................................................................. 44 
9.4 METHODS ............................................................................................. 48 
9.5 STATISTICAL ANALYSES ....................................................................... 49 
10. RESULTS AND SYNOPSIS OF PAPERS .......................................... 51 
10.1 PAPER  # 1 ......................................................................................... 51 
10.2 PAPER # 2 ......................................................................................... 51 
10.3 PAPER # 3 ......................................................................................... 52 
10.4 PAPER # 4 ......................................................................................... 53 
11. DISCUSSION ......................................................................................... 55 
12. CONCLUDING REMARKS AND FUTURE PROSPECTS ............ 63 
13. REFERENCES ....................................................................................... 67 




2. SCIENTIFIC ENVIRONMENT  
The present study was performed at the Department of Otolaryngology/Head and 
Neck Surgery, Haukeland University Hospital and the Department of Clinical 
Medicine, Faculty of Medicine, University of Bergen. 
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ANOVA Analysis Of Variance 
BOTOX Botulinum Toxin 
CAPE-V  The Consensus Auditory-Perceptual Evaluation of Voice 
DSI   Dysphonia Severity Index 
dB  Decibel 
E  Emotional 
ELS  The European Laryngological Society 
ENT  Ear-, Nose-, and Throat 
EORTC The European Organization of Research and Treatment of Cancer 
EPI   Eysenck Personality Inventory 
EPM   Endolaryngeal Phonomicrosurgery 
F  Functional 
F0  Fundamental Frequency 
GRBAS Grade, Rough, Breathy, Asthenic and Strain 
H&N  Head and Neck 
HNSCC Head and Neck Squamous Cell Carcinoma 
HUH  Haukeland University Hospital 
HRQoL Health-Related Quality of Life 
Hz  Hertz 
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MANOVA  Multivariate Analysis Of Variance 
MCT   Manual Circumlaryngeal Therapy 
MDVP  Multi-Dimensional Voice Program  
MPQ   Multidimensional Personality Questionnaire 
MPT  Maximum Phonation Time 
MTD   Muscle Tension Dysphonia 
MTVD  Muscle Tension Voice Disorder 
NHR  Noise to Harmonic Ratio 
NLS   National Norwegian Laryngectomies 
P  Physical 
PROM Patient-Reported-Outcome-Scales 
PVD   Psychogenic Voice Disorder 
QLQ  Quality of Life Questionnaire 
QoL  Quality of Life 
REK  The Regional Committee for Medical and Health Research Ethics 
RFS   Reflux Finding Score 
RLN   Recurrent Laryngeal Nerve 
ROC   Receiver Operating Characteristic 
RSI   Reflux Symptom Index 
SD  Standard deviation 
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SLN   Superior Laryngeal Nerve 
SLP   Speech-Language Pathologist 
STATPED National service for special needs education (Statlig spesialpedagogisk 
tjeneste ). 
SVEA  Stockholm Voice Evaluation Approach 
TE   Thyroidectomy 
UVFP  Unilateral Vocal Fold Paralysis 
VAPP  Voice Activity and Participation Profile 
VHI  Voice Handicap Index 
VHI-30N Norwegian version of VHI  
VLS   Video Laryngostrobo-Scopy 
VoiSS  Voice Symptoms Scale 
VOS   Voice Outcomes Survey 
VPA   Voice Profiles Analysis 
VRQOL Voice Related Quality of Life  




Voice-related diseases may influence on individual’s daily life. Quantifying the 
extent of laryngeal pathology, voice symptoms and evaluating treatment responses 
for patients are challenging. The European Laryngological Society (ELS) has 
proposed a basis protocol for assessment of voice-related disease. Aims of this 
protocol include comparison of treatments of voice related diseases across cultures as 
well as assessing the impact of voice disorders on the health of the patient. ELS 
suggests to include both patient related outcome measures (PROM) and physical 
studies of the voice as part of assessment of voice related disease. 
 
Voice Handicap Index (VHI) questionnaire, a validated instrument on self-reported 
speech challenges, was translated to Norwegian and tested psychometrically and 
clincially. In the first study, we aimed to study 126 voice-related disease patients and 
126 controls answering the VHI-30N questionnaire. The VHI was translated to 
Norwegian following a formal forward-backward translation of the questionnaire 
from English to Norwegian. Our main finding, was that the VHI was 
psychometrically well functioning, and discriminated well between healthy and  
patients with voice disease. 
 
In the second study, we aimed to study the ability to discriminate between voice-
diagnoses dependent on disease origin, based on the VHI questionnaire. We also 
wanted to study the psychometrics of the VHI based on specific laryngeal diseases. 
The impact of different diagnoses on the VHI score, and on the cut-off values was 
also studied. The study was designed as a multi-center-study, including Haukeland 
University Hospital and Statped in both Bergen and Oslo. A total of 126 healthy 
subjects and 355 patients answered the VHI-30(N). We concluded that the Norwegian 
version of the VHI questionnaire was psychometrically well functioning, also when 
studied among different laryngeal disease patients specifically. When deploying large 
groups of patients, the VHI-30(N) had the capability to discriminate between voice-
diagnoses dependent on disease origin. 
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The third study aimed to investigate the importance of including general Health-
related quality of life (HRQoL) measures to clinical investigations. The participants 
(N= 80 larynx cancer, N=32 recurrent palsy, N=23 dysfunctional, N=75 
degenerative/inflammation, N=19 various) were included consecutively at the 
laryngology clinic at Haukeland University Hospital. In addition, HRQoL data were 
included from one national group with laryngectomies (N=105), one group with 
various former HNSCC patients (N=96) and one population-based reference group 
(N=1956). EORTC QLQ, voice handicap index (VHI) and the Eysenck Personality 
Inventory (EPI) neuroticism scores were obtained in the presently recruited patient 
group. 
 
A total score for global QoL/health index was calculated, in addition to scores based 
on function and symptoms. In particular, patients with recurrent palsy and laryngeal 
cancer reported decreased HRQoL. At the index levels, in particular dyspnea scores 
were scored dependent on larynx disease group.  The VHI score correlated with the 
EORTC H&N35 “speech” index with a common variance about 50 %. VHI scores 
correlated with level of neuroticism with eight percent and EORTC scores with 22 %.  
 
The fourth study aimed to study acoustic voice analyses, maximum phonation time 
(MPT) and Voice Handicap Index (VHI) in clinical investigations. The participants 
(N= 80 larynx cancer, N=32 recurrent palsy, N=23 dysfunctional, N=75 
degenerative/inflammation, N=19 various) were included consecutively at the 
outpatient laryngology clinic at Haukeland University Hospital. In addition, a control 
group of 98 healthy subjects were included.  
 
Voice samples, maximum phonation times (MPT) and VHI score and data on clinical 
examination were obtained for all participants. Based on acoustic analyses, we 
determined the level of jitter, shimmer and noise to harmonic ratio (NHR) as well as 




Among larynx disease patients, acoustic and MPT analyses segregated with all 
determined analyses between patients and control conditions, except the 
dysfunctional group. But also to some extent between various patient groups. VHI 
scores correlated to jitter, shimmer and NHR scores among cancer and 
degenerative/inflammatory disease patients.  
 
In conclusion, a thorough examination of laryngeal patients, as suggested by ELS, 
leads to essential information on the disease. It also forms a comprehensive basis 
when treatment results are evaluated.  
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7.1 THE VOICE  
The voice is important in daily life as crucial for our oral communication, enriching 
social function and well-being. Voice disorders are medical conditions affecting the 
quality of voice production. Voice quality is described by a number of terms in 
different languages and the terminology is a controversial issue. Classification of 
voice quality should ideally be based on specifiable parameters of the voice [1]. 
An often used term for abnormal voice is dysphonia. The term is first described used 
in year 1706, borrowed from new Latin dysphōnia, probably from dys- dys- + -
phōnia (in euphōnia euphony). Alternatively, the new Latin word could be borrowed 
from Greek dysphōnía "roughness of sound." The term aphonia was first used in year 
1654 (from new Latin and Greek) from Greek aphōnia, from aphōnos voiceless, from 
a- + phōnē sound [2].  
ANATOMY AND PHYSIOLOGY OF THE VOICE ORGAN 
The larynx is positioned at the interphase between airways, esophagus and pharynx at 
the top of the trachea. It protects and keeps the airways open. The larynx has an 
advanced valve function associated with airway protection and air passage. The 
larynx also regulates the resistance to air passage during inspiratory and expiratory 
phase of the respiration [3].  
The larynx plays a key role during speech as a sound transducer by producing the 
fundamental tone which, in the resonance space above the larynx, form the basis of 
the voice's sound. The sound waves come into being trough pressure changes in the 
airflow between the vocal folds (rima glottidis). Rapid and repetitive alterations of 
rima glottidis due to wave movements (glottic waves) along the edges of the vocal 
folds create these pressure changes. The theory that has won the most support as a 
description of sound production in the larynx is the aerodymanic myoelastic theory 
put forward by van den Berg (Ref from 1958) [4]. This theory is based on several key 
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elements; the aerodynamic principles explain how the forces acting on vocal folds 
develop when air from the trachea passes through the vocal tract [5]. The myoelastic 
elements (“the body and cover”) refer to anatomy and physiology of the vocal folds. 
The outermost layer of mucosa at the vocal folds rim move smoothly over a sliding 
layer (lamina propria). Elasticity below this layer is governed by muscles and 
connective tissue in the vocal folds. Finally, a muscularly controlled positioning of 
the vocal folds is required for the vocalization [6]. When all elements are in place, 
sufficient glottic waves along the rim of the vocal folds are in place to produce voice 
sound. Regulation of pitch is related to tension and molding of the vocal folds, e.g. 
elongation and increased vocal fold tension decrease the glottic wave amplitudes, 
increase wave frequency and thereby raise the pitch.   
 
7.2 EXAMINATION AND EVALUATION OF VOICE-
RELATED SYMPTOMS 
Evaluation of voice-related symptoms includes to study both the symptom(s) the 
patients experience related to voice production and the listeners evaluation of the voice. 
A patient may also be voice diseased despite normal voice sound due to intermittent 
symptoms, or due to the patient perceives that the voice does not work properly despite 
observed healthy voice function [1]. Patients with voice related symptoms are ideally 
examined and treated by a team consisting of, among others, of ENT doctors and speech 
therapists [3].  
The voice quality is the result of several physiological conditions. The length, 
thickness and degree of muscle contraction of the vocal cords, the size of the vocal 
tract, the shape of the resonance space and the air from the lungs affect the quality of 
the voice. 
The quality of the voice is most often judged by measuring deviations from the norm. 
The perception of a normal voice quality may, however, also vary culturally and 
geographically.  
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Fundamental registration of clinical findings and anamnestic information should 
basically be measured as systematic, reliable and valid as possible. The European 
Laryngological Society (ELS) has proposed a basic protocol for the assessment of voice 
disorders [7]. Such a protocol guides physicians to perform systematic examinations and 
offers records for patient information and collegial discussions. To apply the ELS 
guidelines also makes it easier to compare studies of voice-related disease across 
research centers. Some key principles are set as guidelines. Among these, there are five 
elements that should be included in the laryngological examination. These are: 
 
1. Video-laryngo-stroboscopy which is a visual examination of vocal cord function.  
2. Assessment of voice quality by listening to the voice.  
3. Acoustic analyses (analyses physical deviations in the voice's sound quality 
and rhythm, preferably by means of both clinician and computer-based analyses).  
4. Aerodynamic examinations (the simplest test is maximum phonation time).  
5. Patient-reported outcome measures (PROM) for the significance of the voice-
problem assessed by the individual patient. 
 
There is no standard how voice quality should be measured, but there is some 
consensus in the literature that voice is a multidimensional phenomenon that include 
both voice quality and voice production [8]. Dejoncker's guidelines for examining 
vocal defects with a perceptual and acoustic analysis, video-laryngo-stroboscope, 
aero-dynamic examination and subjective assessment from the patient incorporate 
such a perspective and may therefore be used for assessment of voice quality and 
underlying disease [9-11].  
Nest follows a more detailed presentation of the investigations that should be used 




Video laryngoscopy is readily performed with standard equipment in a laryngological 
laboratory placed at an ENT outpatient clinic. The patients' larynx is examined either 
with 70 degree angle optics or with flexible instruments accessed via the nose. A 
stroboscopic light source gives a flashing light set to the frequency of the voice. 
When regulating the frequency slightly out of phase with the voice oscillations 
(glottic waves), one can view these fluctuations in slow motion, along the edges of 
the vocal folds. There is a close connection between the voice quality and the 
structure of the glottis waves. Furthermore, minute changes in the stretch of one vocal 
band can result in changes in the glottis wave. Stroboscopic light aided examination 
can therefore contribute to more accurate assessment of the motor movement of the 
vocal cords and therefore aid evaluation of the vocal cord’s function. Pertinent 
findings may be graded according to a method developed by Hirano modified by 
Bless and allied [3] which is one of the best method so far published. In short, this 
method involves grading irregularity in the stroboscopically generated waves; i.e. 
their frequency variations and variation in amplitude. The Hirano-Bless method has, 
however, so far not proven particularly useful in our laboratory. Video laryngoscopy 
will usually provide specific laryngological diagnoses. If the video recordings are 
stored, one can also subsequently later retrieve relevant recordings and compare any 
changes over time.  
 
7.2.2 Assessment of voice quality by listening to the voice  
Doing perceptual analysis of voice quality, one listen for specific voice parameters 
according to a pre-set definition. These parameters are often assigned to specific 
physiological and acoustic characteristics of the voice [12]. Perceptual analysis has 
been considered a gold standard for documenting voice quality; partly because voice 
quality can be considered a natural perceptual characteristic [13]. In addition, this 
method places no demands for advanced equipment. However, a main criticism of 
clinical use of perceptual analysis is that it is observer dependent. The perceptual 
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analysis of voice quality is nevertheless of potentially importance, as it may provide 
valuable information in the investigation of the cause of voice impairment and 
assessment of treatment effect [13]. Instrumental measurements cannot replace 
auditory-perceptual analyses as shown by Dejonckere and allied [7]. Various 
approaches have been investigated for perceptual analysis of voice quality. One 
challenge with perceptual analysis in clinical work is, however, how the individual 
speech therapist judge the different voice parameters [14]. Perceptual analysis seems 
to require a lot of training by listening to different voice qualities for the individual 
speech therapist. When conducting studies of perceptual analysis of voice quality, 
there is furthermore a need for a standardized voice recording in order to define the 
actual scoring[7]. One usually records the reading of a standard text with about 40 
seconds duration [15]. 
 
One of the first developed measuring instruments for perceptual analysis of voice 
quality was the GRBAS scale [16]. GRBAS was developed from Osgood's semantic 
scales [12] and consists of an analysis of opposite adjectives, for example, breathy - 
strained. Parameters considered are Grade (general assessment), Rough (roughness / 
irregularity), Breathy (air-filled), Asthenic (low-sounding) and Strain (excited / 
pressed). Scoring are from 0-3. Freitas and coworkers compared four computer 
programs for acoustic analysis of voices with the GRBAS form. They found the 
strongest correlation with Breathy, while Asthenic and Strain were the weakest [17]. 
The test has been used clinically in a Norwegian version by Haukeland University 
Hospital (HUH). 
Another widespread perceptual analysis guide is Voice Profiles Analysis (VPA) [18]. 
VPA includes scoring of both laryngeal and supra-laryngeal voice characteristics 
[12]. Different parameters that are considered are hoarseness, whisper voice, 
scrubbing, folding / modal register, and whether the voice is tense or lax [12]. 
Prosodic traits, voice pitch and variation in this are also considered together with 
voice strength and temporal traits such as speech rate [12]. 
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The form The Buffalo III Voice Profile [19] aim to assess 12 voice parameters on an 
interval scale from 1-5, where 1 is normal and 5 is very serious deficiency in quality. 
One can analyze laryngeal tone, pitch, strength, nasal resonance, oral resonance, air 
supply, muscles, abuse of voice, voice punch, understandable speech, and overall 
voice assessment. 
Stockholm Voice Evaluation Approach (SVEA) is a Swedish developed form aimed at 
perceptual analysis. This analysis considers 26 different parameters. The form is also 
available in a clinical version containing 14 parameters [12]. Voice properties such as 
aphonia, leakage hyper- and hypofunctional, scrub, harsh approaches, unstable 
sound/voice, register-breakdown, and diplophonia are considered. One also measure 
voice and voice-power. Tveterås at Bredtvet competence center in Oslo, in close 
cooperation with Hammarberg with aid from Huddinge University Hospital in 
Stockholm, has developed a Norwegian version of this form [20, 21]. The scale, both 
in Swedish [15] and Norwegian [20], was first designed employing a Likert scale 
response pattern, but it has later been changed to 100 mm visual analogue scale 
(VAS) [12, 21]. 
The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) [22] is another 
form that includes the voice parameters degree of hoarseness, screaming, leaking, 
pressure, voice and voice [12].  
 
Berg has compared CAPE-V and SVEA [23] Swedish versions, and found that 
CAPE-V can distinguish treatment effect for patients with certain organic voice 
disorders, while SVEA has several parameters of clinical relevance, such as 
diplofonia. Berg concluded that CAPE-V or GRBAS are good alternatives if 
treatment effects are to be assessed. If one want to understand more of the underlying 
physiology behind a voice disorder, map changes in voice function over time or find 
acoustic correlates, a perceptual analysis form must be used that includes several 
specific and characteristic voice parameters for a voice disturbance. [12]. In this way 
the SVEA will be better. Carding, Carlson, Epstein, Mathieson & Shewell [8] has 
compared GRBAS, VPA and The Buffalo III Voice Profile. They recommend the 
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clinical use of GRBAS, but find that there is still a need to further develop analytical 
dimensions that are realistic for clinical use, theoretically anchored, internationally 
accepted and have demonstrated reliability. We have started the work to implement 
the GRBAS test into our measurement armamentarium, but has so far not reached a 
level which is required in a scientific setting. 
 
7.2.3 Acoustic analyses 
Physical change in the larynx, or of motor control of the larynx will affect the 
acoustic character of a voice [5]. Changed voice quality may also be found in 
functional disease [24]. In order to study physical characteristics of the voice acoustic 
analysis may be performed using a computer program based on a digital audio 
recording [25]. The software digitizes the voice sound and gives goals for voice 
quality. 
 
In this study, the program Multi-Dimensional Voice Program (MDVP) from Kay 
Elemetrics, USA (part of their Computerized Speech Lab suite) has been used. 
Among programs for acoustic analysis of voices, MDVP is widely used clinically and 
research wise [26-28]. Freitas and coworkers have compared four computer acoustic 
analysis programs, and the GRBAS perceptual observer analysis form [17]. They 
found a relationship that varied from weak to moderate. The variations between the 
computer programs were, however significant. In part due to the lack of 
standardization of the algorithms the different programs use, the results must 
therefore be viewed in the context of the chosen analysis tool. 
MDVP calculates up to 33 parameters from the voice recordings, and the various 
parameters are considered variable valuable and reliable [7, 29-31]. ELS' protocol [7] 
recommends primarily the use of the basic frequency, relative jitter and relative 
shimmer as the basic acoustic measurements. These authors also point out the 
harmonics-to-noise ratio among the most "robust targets", but point out that between 
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software for acoustic analysis it is currently inadequate standardization of this 
parameter. These four parameters are common parameters in acoustic analysis [27, 
32]. The corresponding four parameters of the MDVP used in this study are 
respectively fundamental frequency (Fo), jitter percent (Jitt), shimmer (Shim) and 
noise to harmonics ratio (NHR). 
In a review article [31] the authors studied MDVP in use together with among others 
Voice Handicap Index (VHI) [33]. The authors highlight the four above mentioned 
MDVP parameters among the nine parameters that they consider "the acoustic 
parameters which give the most objective information about the presence of vocal 
modification" [31]. 
 
Fundamental frequency (Fo).  
A frequency is defined as the number of complete oscillations per second. For the 
voice, this means the number of complete open-close cycles of the vocal cords per 
second. The assigned unit is Hertz (Hz). The parameter Fo is a measure of the 
average voice frequency of the voice, that is, the component of the voice frequency 
with the lowest frequency [5]. The base frequency of the voice can also be referred to 
as the voice's fundamental tone. Higher frequencies related to (the product of) the 
fundamental frequency is called harmonies or overtones - at base frequency 200 Hz 
one can find harmonies of 400 Hz, 600 Hz, 800 Hz and so on. According to 
Traunmüller and Erikssons [34] summary of ten studies, the base frequency of the 
voice is average of 119 Hz (SD: 2.8) for European men and 207 Hz (SD: 2.7) for 
European women. Preciado, Pérez, Calzada og Preciado [35] found slightly higher 
fundamental frequency values in their control group. When they analyzed maintained 
vocal / α / with MDVP, males had 154.7 Hz (SD: 32.46) and females had 228.7 Hz 
(SD: 37.74). 
For men, the fundamental frequency drops to fifty years before it marginally rises, 
while women's fundamental frequency drops until the sixties before it rises somewhat 
[36]. Men have more change in fundamental frequency rate during their lives than 
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women. F0 can also vary during the day. It turns out that people who use the voice a 
lot during a day can have significantly higher fundamental frequency at the end of the 
day compared to the beginning of the day [37, 38]. 
 
Jitter percent (Jitt).  
Jitter is defined as the instability of the vocal cords' wave motion [5, 25]. The Jitt 
parameter calculates the degree of variation from oscillation to oscillation in percent 
of the fundamental frequency of the voice (F0). Thus, a low jitter's score indicates 
smooth wave movements of the vocal cords. Jitter is also reported in some literature 
as frequency perturbation. In the control group in a study of Preciado and Allied , 
males had a Jitt score of 0.632 (SD: 0.49) and females 0.707 (SD: 0.43) [35]. 
Shimmer (Shim).  
The amplitude is a measure of a sound's volume in decibels (dB). The Shim 
parameter is a percentage measure of amplitude instability and calculates the degree 
of variation from oscillation to oscillation of the amplitude of the voice [5, 25]. A low 
shimmer score indicates smooth volume in the voice. Shimmer is also in some 
literature referred to as amplitude perturbation. In Preciado and allied [35] control 
group had men a Shimmer score of 2.494 (SD: 1.11) and women 2.905 (SD: 1.65). 
Noise-to-harmonics ratio (NHR).  
Noise can be defined as random, aperiodic energy in the voice [5]. The NHR 
parameter seeks to provide a measure of noise in the voice recording [25, 36] 
measured in dB. This is done by the fact that sound on the recording which is not 
related to the fundamental frequency or its harmonics is considered noise. Since no 
voice is completely "clean", healthy voices will have different amount of noise, and it 
is challenging to define the distinction between normal and abnormal noise. Noise in 
the voice may have two sources; there may be a noise source near or at the vocal 
cords (for example, airflow through open vocal chords) or significant aperiodicity in 
the vocal cords' wave motion [5]. These two sources of noise may produce similar 
acoustic effects, and thus be difficult to distinguish between based on how it sounds, 
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but the presence of noise will separate both from healthy voices. NHR gives a ratio 
value where low score (near 0) indicates low noise and high score (near 1) indicates a 
lot of noise. Preciado and allied [35] states the following NHR values for their control 
group: males had 0.132 (SD: 0.025) and females had 0.127 (SD: 0.21). Freitas and 
allied found that of the above parameters, shimmer and NHR had the best predictive 
value compared to jitter. The variation between different software programs were also 
substantial [17]. 
 
7.2.4 Aerodynamic examination - maximum phonation time 
For the aerodynamic approach, the maximum phonation time (MPT) of the held 
vowel / a / which has the longest duration for each informant is measured. MPT 
provides a simple value in seconds for how long a person can produce a continuous 
sound. MPT is according to the ELS' [7] protocol the simplest and most widely used 
aerodynamic parameter. Poor closing of the vocal cords will cause short MPT since 
the air in the lungs cannot be used effectively during expiration. There has been 
shown a relationship between MPT duration and pathology in the larynx [39]. 
 
7.2.5 Patient-reported outcome measures (PROM) 
Several different instruments have been developed for quantitative PROM related to 
voice disease. One of the most internationally used measuring instruments is: 
 
 Voice Handicap Index (VHI) [33], and short versions of this: 
o Voice Handicap Index-10 (VHI-10) [40] 
o Voice Handicap Index-9 (VHI-9) [41].  
 
Developed by a group at the Henry Ford Hospital in Detroit VHI consists of 30 
statements (items) that can be divided into 3 sub-scales each including 10 statements: 
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Emotional, Functional and Physical [33]. The informants consider the extent to which 
each statement (item) fit themselves by putting a ring around this answer option 
derived as a Likert scale: never (0), almost never (1), sometimes (2), almost always 
(3) and always (4). VHI is the most widely used laryngology PROM questionnaire 
today. It has been translated into many languages with validity and reliability tested 
and found satisfactory. Verdonck-de Leeuw et al. [42] has compared the results from 
VHI in several different languages: English (US), English (UK), German, French, 
Dutch, Italian, Portuguese, Belgian and Swedish and found them psychometrically 
satisfactory. In addition, this questionnaire has been translated into among other 
languages Chinese [43], Spanish [44] and Arabic [45]. In recent years has Persian 
[46] and Latvian [47] been added. A formal presentation of some of the different 
translations of the VHI has been presented in table 1. 
 
Other PROM instruments in use are; 
 
 Voice-Related Quality of Life (VRQoL) [48]  
VRQoL was developed staring with patient interviews. The test consists of 10 
questions that can be divided into two subgroups; 1) socially-emotional and 2) 
physically-functional. Several questions in this questionnaire and VHI are similarly 
formulated. 
 
 Voice Symptom Scale (VoiSS), [49]  
VoiSS includes 30 questions. The aim was to develop and validate a patient-derived 
battery with questions aimed at voice symptoms, which can be used as a sensitive 
assessment tool in order to assess reported voice pathology, and to capture perceived 
changes among voice-diseased patients in clinical everyday life. 
 
 Voice Activity and Participation Profile (VAPP), [50].  
This test consists of 28 questions divided into five subgroups; self-perceived severity 
of the voice problem, impact on work, impact on daily communication, impact on 
social communication and emotional impact. 
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 Voice Outcomes Survey (VOS), [51].  
The test consists of five questions with five response options. It aims to measure 
disease-specific health conditions in people diagnosed with recurrent palsy. 
 
All the above mentioned instruments have been found to be valid and reliable studied 
in the original language. Franic and allied compared 9 of these PROM tests [52]. Of 
these, 4 were selected for a more comprehensive review: VHI, VAPP, V-RQOL and 
VOS. These instruments were evaluated based on 11 measurement standards related 
to item-information, versatility, practical use, breadth and depth of health goals, 
reliability, validity, and sensitivity. Both VHI and V-RQOL met 7 of the 11 criteria, 
but VHI performed better on item-information, practical use and reliability compared 
to V-RQOL, while V-RQOL showed higher sensitivity compared to VHI. Agency for 
Health Care Research and Quality reported in 2002 that VHI met their strictest 
criterion for reliability, validity and availability of normative data [53]. There is a 
need for Norwegian translations of the above mentioned tests. Two of the tests have 
been translated into Norwegian: Voice Handicap Index (VHI-30N) [54] and Voice-
Related Quality of Life (V-RQOL) [55]. Formally reporting about the translation of 
VHI into Norwegian, as well as psychometric testing of this translation has been the 
initial study in this thesis.  
 
An additional important question is to what extent VHI scores differently between 
different laryngological diseases. Several studies have used VHI scores to show the 
effect of laryngological treatment [56-58] (Table 1). If VHI may be used as such, 
VHI should ideally distinguish between less and more serious laryngeal diseases. It 
may further be assumed that the cut-off value of the VHI between healthy subjects 
and laryngeal diseased may be affected by their specific diagnosis. These are current 
unanswered questions that are well suited for scientific studies, and are therefore 
among the hypotheses that are raised in current thesis. 
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7.3 Quality of Life 
7.3.1 Quality of life term 
Historical development 
The term quality of life (QoL) is often used in daily life [59]. In the everyday 
language, the term may have different content, such as being satisfied with life, well-
being, happiness, meaning and functional status[60].  
Within a scientific approach to HRQoL, Morton [61] has given a historical overview 
upon which the following is based: 
One of the earliest definitions associated with the concept of QoL is related to 
Aristotle (384-322 BC). He used terms such as perceiving "the good life", 
"successful" or "being happy". But what constitutes happiness can be discussed. 
Aristotle also states that happiness was a state of feeling or a type of activity [62]. 
Hippocrates (~ 460-377 BC) realized that a patient's satisfaction with life and 
psychological well-being was important for coping with disease, but in general, the 
traditional medical perspective was mainly to cure disease, and the patient's 
psychological concern was of little interest. Voltaire (1694-1761) commented on the 
doctors' lack of interest in the general well-being of patients: "Doctors are men who 
prescribe medicine that they know little about, to cure diseases they know less about, 
in humans, which they do not know anything about". 
Illness will obviously affect QoL. The phenomenon was already recognized by 
Lichtenberg (1742-1799), who stated that "the feeling of health is obtained only 
through illness". But in general, the QoL was rarely mentioned in medical scientific 
literature up to the 20th century. Specific QoL in relation to patients' health came at a 
later point. 
 
Definition & Content of the Quality of Life concept 
A question of interest has also been how the QoL concept can be related to specific 
symptoms that have been caused by an illness, or focus on the general well-being of 
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the individual. The Department of Mental Health of the World Health Organization, 
WHO (1995)[63]defines QoL as: "an individual's perception of their position in life 
in the context of the culture and value systems they live in and in relation to their 
goals, expectations, standards and interests". This definition is general. Other 
researchers regard high QoL as the subjective evaluation of the good and satisfactory 
life as a whole [64]. The same is supported by Gotay and Moore [65], who defined 
QoL as the experience of well-being composed of two components: the ability to 
carry out daily activities that reflect physical, psychological, and social well-being, 
and the patient's satisfaction with the degree of functioning and control of disease. 
The same type of definition has also been supported when QoL was defined as an 
individual's total satisfaction with life and general perception of personal well-being 
[66]. 
Ferrans [67] has focused on what the important part of the QoL of an 
individual is, by defining QoL as: "a person's perception of well-being derived from 
satisfaction or dissatisfaction with the areas of life that are important to him/her ". On 
the other hand, other defined QoL has to represent the functional effect of a disease 
and its treatment on the patient [68]. Today, both approaches are often represented in 
the tests used. 
Many have also argued that an operational definition is preferable. QoL is 
measured with a specific questionnaire which then defines QoL. Which quesitions to 
include, can obvioussly be discussed. Consequently, it is possible to build a specific, 
empirical definition. Examples of such empirical definitions are by Padilla and co-
worker [69], which defined HRQoL as: "a personal, evaluative statement 
summarizing positive or negative traits that characterize a psychological, physical, 
social, and spiritual well-being. a time when health, illness, and treatment conditions 
are relevant ”. Many of the QoL-instruments used today have major influence from 
this approach. 
Several researchers have suggested that QoL can be a multi-level construction. 
Spilker [70] suggests these three levels: 
1. Total assessment of well-being. 
2. Wide domains (ie Physical, physiological, economic, spiritual, social). 
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3. Components of each domain. 
These levels underline the complexity of the concept of QoL. 
 
It is obvious that observed from the outside, a person with seemingly low QoL 
can have an excellent QoL based on his or her own assessment. This has been 
formulated as "the gap" theory [71]. The gap is the difference between current 
experience on the one hand and perceived goals on the other [72]. QoL may also be 
formally stated as the gap between patients' expectations and achievements. The 
smaller the gap, the higher the QoL [72]. Such a suggested QoL definition is: "The 
perception of the discrepancy between the reality of what one has and what one wants 
or waits constitutes the QoL" [69, 73]. The same mindset is also emphasized in the 
WHO's QoL definition, which states that QoL is the patient's perception of their 
position in life in the context of culture and value systems in which they live, and in 
relation to their goals, expectations, standards and interests [63]. 
It has also been shown empirically that QoL scored by health personnel can 
give significant differences compared to the assessment by the patient him or herself 
[74-76]. Today, there seems to be general agreement that QoL is a matter of personal 
self-scoring judgement [71, 77]. 
 
7.3.2 General Quality of Life Measures 
In recent years, there has been an increasing number of studies on QoL in patients 
after undergoing treatment for various diseases. One area of interest is the QoL of 
patients who have been successfully treated for head & neck cancer [78-81]. At the 
ENT department, Haukeland University Hospital (HUH), one has systematically 
studied the QoL of successfully treated head & neck cancer patients over a fifteen 
year period [82-84]. Some of these patients have laryngological disease in the sense 
of laryngeal cancer. The findings made for head &  neck cancer patients in general, 
are also shown to be valid for laryngeal patients with a cancer disease. It will 
therefore be of interest to study to what extent HRQoL findings made for laryngeal 
cancer patients also apply to patients with other laryngeal disease. 
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We aim to use "The European Organization of Research and Treatment of Cancer" 
(EORTC) questionnaire to measure general QoL (EORTC-QLQ-C30) in this study, 
based on previous experience with the form in head & neck cancer patient studies at 
ENT department, HUH [85-87]. This questionnaire can also be used for diseases 
other than cancer [88]. Using this questionnaire for other diseases will also broaden 
the knowledge base for QoL in cancer. 
 
7.3.3 Symptom-specific Quality of life Measures 
The EORTC QLQ system assumes that, in addition to general QoL, the disease-
specific HRQoL should also be measured. We have chosen to use EORTC QLQ H 
& N35 [89] targeting head-neck cancer patients. The head & neck section consists of 
fourteen symptom items that are presented in eighteen questions and eight function 
items that are presented in twelve questions. Descriptive items about pain, nutrition 
and weight are also included. The head & neck-specific part is developed in Norway. 
Relevant questions from this test can also be asked patients with benign laryngeal 
disease. 
 
It has been found that there is little correlation between perceived QoL and expected 
sequels after undergoing treatment [90]. What has been found, however, is that 
personality traits and the choice of coping strategy are of importance for the QoL 
judgement in patients after having undergone head & neck cancer treatment. Such 
results are based on collected values for the QoL quality, personality traits, coping 
methods and level of social support in all patients who were successfully treated for 
head & neck cancer at the ENT department, HUH [79, 85, 91].  
 
VHI is considered a Patient-Reported Outcome Measures (PROM). It is not clear to 
what extent VHI overlaps with classical QoL questionnaires. Lundstrøm and allied 
have studied the association between VHI and EORTC score levels in patients who 
had undergone laryngectomy, and found that these complement each other well [92]. 
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VHI may therefore be studied in relation to an established QoL measuring 
instrument. This has a goal included in the current thesis. As such it is of interest to 
study to what extent personality traits affect the VHI score, and this is one of the 
objectives of the current thesis. It is furthermore of interest to compare the reported 
QoL of patients with laryngeal disease with scores from the population as a whole. 
 
7.4 The Personality Aspect 
Historical development 
Personality has been studied scientifically for more than a century; scientifically since 
Freud introduced psychoanalysis around 1900 [93]. Psychoanalytic theory has a 
psychodynamic, clinical approach to personality. Two sets of levels are important as 
structural concepts: deliberate, conscious, and unconscious. The other concept level is 
related to id, ego, and superego. 
Individuals go through different stages of development, according to Freud 
[93]. The oral, anal and phallic steps have been a focus of psychological personality 
development as well as research regarding these questions. The psychoanalyst 
Erikson also expanded the vision to cover psycho-social development. Early 
experience, especially the four to five first years of life, is important in the Freudian 
theory when it comes to personality development [93]. 
Many early analysts extended the Freud theory frame. Adler emphasized social 
aspects, while Jung generalized more on life energy than specific sexual energy. 
Others emphasized cultural factors and interpersonal relationships. Clinical 
development in psychoanalysis has recently focused on self-definition and self-
esteem. The Freudian theory seems, howver, to suffer from being ambiguous, with 
unclear defined terms, and difficult to test in relation to specific hypotheses [93]. 
The trait concept has been supported by various psychologists. Eycenck 
suggested that people have extensive predisposition to respond in particular ways, 
which were called character traits [94]. He claimed that the personality had a 
hierarchical structure with a specific response level, a habitual level, trait level and 
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super-factor level, as for Eysenck, for example, was extroversion or neuroticism. 
Allport believed that character traits represented basic units in the personality and 
defined them based on characteristics such as frequency, intensity and scope of 
situations [95]. 
The three-factor theory of Eysenck is based on factor analysis. He found two 
basic dimensions of personality and called them introversion - extroversion and 
neuroticism [94]. He also later added a third dimension, psychoticism [96]. 
Cattell also had a factor-analytical approach to character traits. He 
distinguished among three methods: bivariate, multivariate and clinical studies of the 
personality. Cattell was interested in the correspondence between behavior and 
personality, but also focused on motivational processes. In addition, he used the term 
state to refer to mood and emotional change. Examples of conditions are anxiety and 
depression [97]. 
Character theorists such as Allport, Eysenck and Cattell agree on the presence 
of broad personality dispositions, but they differ in other approaches. Allport is 
critical to factor analysis, but Eysenck and Cattell use it. They also disagree with the 
number of character traits in the description of the personality. It is, however, among 
contemporary character theorists a development toward consensus around "The Big 
Five" dimensions [93]. 
Critics of character theory emphasize that human behavior is variable. Some 
also argue that the importance of situational influences should be emphasized. This 
has been called the person-situation controversy. There is evidence of longitudinal 
stability of the traits, also over extended periods of time [98]. Although personality 
can change, it is forces that work to maintain personality stability over time. In 





In order to define the term personality we can ask how the term is used in our daily 
lives. It deals with continuity, stability or consistency about what a person does, 
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believes or experiences [100]. This is also how Pervin and John define personality: 
"Personality represents the characteristics of the person explaining consistent patterns 
of feeling, thinking and behavior" [93]. Or it can be defined as McCrae & Costa (in 
Wiggins, 1996): "A system defined by personality traits and the dynamic processes 
through which they affect the psychological functioning of individuals" [98]. 
 
The personality five-factor model, has been developed for over fifty years [101] and 
is still considered a contemporary valid theory [102]. According to the five-factor 
model [103], personality can be perceived as divided into: 
 
1. Neuroticism: Neuroticism is an emotional factor. The people who score high on 
this tend to be emotionally insecure people who are chronically anxious. 
 
2. Extraversion: Extraversion assesses quantity and intensity of interpersonal 
interaction, activity level, need for stimulation and capacity for joy. An extraverted 
person is person-oriented, optimistic, likes to have fun and loving. People with low 
scores on this are reserved, sober, task oriented and quiet. 
 
3. Openness to Experience: This has to do with culture. High scoring people are 
curious with broad interests, creative and untraditional. The low scoring person is 
conventional, with narrow interests and non-analytical. 
 
4. Agreeableness (pleasure): This is the opposite of hostility and irritability. This trait 
reflects a continuum from compassion to resistance in thoughts, emotions and 
actions. An Agreeable person is person-oriented, optimistic, likes to have fun and 
loving, good-hearted, nice and helpful. The low-scoring person is characterized as 
being cynical, rude and manipulative. 
 
5. Conscientiousness: The factor reflects the will to achieve something and to be 
accountable. The trait is related to people's degree of endurance in goal-oriented 
behavior. The highly scoring person is characterized as being hard-working, self-
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disciplined and ambitious. The low-scoring person is characterized to be pointless, 
careless and unwilling. 
 
Eysenck Personality Inventory (EPI) 
Eysenck Personality Inventory (EPI) is one of the most widely used and used tests in 
the field of personality research. It is a questionnaire consisting of fifty-five questions 
/ statements. Eysenck originally published a test that was to measure neuroticism and 
extra-introversion along with a lie scale [104]. He later added a psychoticism scale to 
the test [96]. Neuroticism (twenty four questions), extra version (twenty-four 
questions) and the lies (nine questions) are dimensions of Eysenck personality 
inventory [104] based on the informants responding YES or NO to each question in 
accordance with their own perception of it their self. The scales are calculated as sum 
score. The test has been translated into Norwegian, and is well documented in 
relation to validity and reliability [105]. 
 
It has been performed limited scientific work to investigate the connections 
between voice impairments and personality, but in 2000 Roy and allied published a 
work comparing personality traits measured with "Multidimensional personality 
questionnaire". Multidimensional Personality Questionare (MPQ) in a control group 
and four groups of patients with different voice-related ailments (functional 
dysphonia, nodules, spastic dysphonia, and vocal cords). They found that there was a 
clear difference between the groups in terms of personality traits. Functional 
dysphonia was related to introverted personality, stress reactions, alienation and 
depression to a greater extent than the other diagnostic groups. Nevertheless, there 







7.5 Voice disorders  
It is common to divide the voice disorders into broad categories; organic, functional 
and neurological, based on the causal factors [107].  
Organic factors are pathological processes, injury or disease, interrupting the function 
of the vocal cords or the laryngeal mucosa [3]. Neurological voice disorders are often 
included into the organic category referring to conditions affecting the neurological 
control of laryngeal structures via the afferent or efferent nerve signals [3]. 
Functional voice disorders often refers to ailments that patients relate to voice use 
without any identifiable physical cause following thorough clinical examination of 
the larynx. The patient may than be unable to utilize a normal functioning larynx to 
create a normal voice [12]. Functional disorders are heterogeneous and emotional. 
Psychological factors play a role in some such patients. Functional voice disorders 
are more common than organic difficulties as patients consulting speech therapists 
[107, 108]. The separation between organic and functional voice disorders may be 
diffuse [109, 110]. A functional disorder can lead to organic changes in the larynx, 
such as when nodules arise from excessive and incorrect use of the voice [9].  
There is no reliable overview of the incidence of voice disorders in Norway. 
According to a study by Grieg [111] including consecutive patients referred to the 
speech therapist at Statped west in Bergen and Statped south-east in Oslo, the 
distribution of diagnoses was as follows: about 3/5 parts functional, about 1/5 organic 
and 1/5 with uncertain diagnosis, most of which have probably an organic cause. 
Speech therapist Elstad performed a study in 1998 based on 250 subsequent clinical 
examinations of patients referred to speech therapy. She found based on this material 
that about half of the patients had functional disorders, while the other half was 
distributed on various organic causes. 
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7.5.1 Organic voice disorders 
According to definition, organic voice disorders are due to conditions that affect the 
voice production i.e. the phonation [9]. Any condition or disease affection the 
function of the larynx may cause disturbances of vocalization (dysphonia/hoarseness) 
and/or affect the respiratory function causing dyspnea [5]. Organic voice disorders 
may be due to congenital or acquired disorders. They may be due to muscle injuries 
or paralysis or damage to the nerve-pathway to the larynx. 
As already mentioned, neurological causes are sometimes presented as a separate 
group. These voice disorders are caused by disturbances of either the central or 
peripheral nervous system [107]. Neurological disorders affecting corticospinal-
fibres, cerebellum, basal ganglia and upper and lower motor neurons may cause voice 
problems [112]. Other causes for neural disturbances may be surgery or trauma [5]. 
When the signalling system does not function properly, control of the motor planning 
and control of the muscles is impaired or even lost.  
The treatment for organic voice disorders is primarily medical or surgical. Some 
conditions may also benefit from pre- or postoperative speech therapy. Examples of 
such conditions are nodules, and other types of abnormal growth where voice use 




Laryngeal cancer may affect the voice production as an organic voice disorder, 
especially when located at the vocal folds.  
The prevalence of laryngeal cancer varies from country to country [113]. Estimates 
from 2009 show 12,290 new cases of laryngeal cancer and 3,660 deaths due to this 
type of cancer globally [114]. Tobacco smoking is the major risk factor for laryngeal 
cancer [113, 115, 116]. Other causes may include alcohol and working environment 
with, for example, a lot of dust from asbestos, gases and chemicals [5, 12]. It is 
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significantly more men than women who develop laryngeal cancer in most countries 
[113, 117]. The incidence among women has increased concurrent with the increase 
of female smokers [114]. The most common cancer type in the larynx is squamous 
cell carcinoma of the vocal folds (glottis cancer). The second most common tumour 
location is cranially to the vocal folds (supraglottic). Tumours under the vocal folds 
(subglottis) are rare, normally estimated from 1% to 5% of the larynx cancer cases 
[12, 113, 114]. 
The primary symptom of glottic cancer is hoarseness. A Finnish study of 312 patients 
showed that hoarseness also was the most prominent symptom of supraglottis cancer, 
but also common to subglottis cancer [113] [2, 68, 69, 72]. If the tumour is localised 
supra- or subglottically, it may develop more than glottic tumours before the 
symptoms appear. Other common supraglottic symptoms are globus laryngus, sore 
throat, dysphagia, and pain by swallowing. If the tumour is large (at any location) it 
can cause breathing difficulties [5, 12]. 
It is often hoarseness that causes the doctor consultation when the cancer is detected. 
At an early stage of glottic cancer, the cancer Appears like a whitish, irregular 
thickening of the vocal cords. If the tumour has developed and grown into the muscle 
tissue, it can lead to reduced vibrations in the vocal cords [12].  
The change of voice quality in patients suffering from laryngeal cancer depends on 
the size and location of the cancer. Tumours outside the vocal cords will not 
necessarily lead to a changed voice [5]. Acoustic targets such as jitter, shimmer and 
noise can reflect fundamental aperiodic vibrations in the vocal cords caused by the 
cancer. Several studies have noted increased disturbances in frequency and amplitude 
with cancer [5, 118, 119]. Colton found slightly higher basic frequencies for the 
vowel / α / and / e / in male patients with T1 and T2 carcinoma and much higher 
baseline rates for the vowels in female patients with T1 glottical cancer compared to 
control conditions. The variation in pitch increased for male patients with T1 and T2 
cancer [5]. 
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Increased noise levels have also been found on in patients with laryngeal cancer, 
especially in the higher frequency ranges [5]. Measurement of noise in the voice 
energy may indicate the severity of cancer. A study of 57 patients showed that Noise-
to-harmonic was pathological of in 77% of T1 cases and all T2-T4 cancer cases 
studied [5]. 
The sub-location of a malignant laryngeal tumour may play a role as to risk for 
metastases. There are few lymphatic vessels around and below the vocal folds. In the 
case of glottis and subglottic cancer, the risk of spreading to lymph nodes is less than 
that of tumour superior to the vocal cords. [114]. 
Radiation therapy used to treat laryngeal cancer usually produces side effects that last 
from a few months to many years. The mucous membranes of the larynx may become 
irritated and cause infections, including fungal infection. The mucous membranes of 
the oral cavity and the pharynx may become brittle and dry, leading to pain and 
swallowing difficulties, as well as hoarseness. Late radiation side effects can be 
oedema and fibrosis in connective tissue, as well as reduced salivary gland function 
with secondary dry mouth. This can lead to speech impairments and reduced 
phonation ability [12]. 
A recently published study compared treatment with radiation and laser surgery in 
patients with T1a glottis cancer compared by voice handicap index (VHI), perceptual 
and acoustic analysis, aero-dynamic examination or stroboscope examination. The 
postoperative voice was air-filled in both groups. The group treated with radiation 
also tended to have a “harder” voice with higher values for jitter in acoustic 
measurement. No difference was significant between the treatments, and the results 
did not show which method ended up with the best voice quality [120]. 
A similar study from 1994 found similar results for perceptual and acoustic analysis, 
as well as subjective assessments. Laser surgery tended to produce slightly better 
results compared to voice quality, but the observed differences between treatment 
methods were not significantly different [121]. A study done at the ENT department 
at Haukeland University Hospital also found no significant difference in voice quality 
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when comparing radiation and surgery using endoscope evaluation [122]. Other 
studies have shown similar results [114]. 
Reinke`s edema 
Fluid accumulation in the vocal cords, in the Reinke`s space (the outer layer of 
lamina propria), is called Reinke`s edema. The entire length of the membranous vocal 
cord becomes oedema-like and swollen [123]. The fibres of the elastic system of the 
outer layer participate in the vibration of the vocal cords. They contribute to the 
mucous membrane of the vocal cord having fluid elasticity. When aging, these fibres 
become naturally larger and coarser, and the elasticity decreases, which causes the 
voice to change. These changes can be observed in people with Reinke`s oedema, and 
may be part of the cause of change in voice following Reinke’s edema [124]. The 
variation and organization of fibre proteins also seems to be important for Reinke`s 
space associated optimal vocal folds function [125]. 
Reinke`s oedema is a relatively common disorder of the vocal cords, and the 
prevalence in patients with vocal defects varies from 5.5% to 7.7%. [126]. Women 
are affected more often than men, and the disorder mostly occurs in people over 40 
years of age [127]. 
The main symptom of this oedema is that the voice's fundamental frequency becomes 
lower [125]. The oedema increases the mass of the vocal cords, causing more slowly 
vibrations. This gives a deeper, hoarser voice. The vocal closure can become 
incomplete, and one gets a dysphonic voice that sounds rough and scrubbed [128, 
129]. Female voices that are affected by Reinke`s oedema often acquire the 
characteristics of a male voice [125].  
Cigarette smoking is recognized as a common cause of this disorder [123, 125, 127]. 
Misuse and too extensive use of the voice can also cause oedema. Reflux, allergy and 
laryngeal disease may also have an impact on this condition [130]. 
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Recurrent palsy  
Recurrence palsy is a paralysis with reduced or deficient ab-and adduction of one or 
both vocal folds due to damage to the Recurrent Laryngeal Nerve (RLN). Defect 
function of the Superior Laryngeal Nerve (SLN) does not affect the vocalization as 
much because the motoric neurons of the SLN to the crico-thyroid muscle regulate 
elongation and tightening of vocal folds, and not the ad- and abduction. SLN is 
placed deep in the neck which protects it from damage, and it is most commonly the 
RLN that is affected [131]. It is most common with a unilateral vocal cord palsy 
[129]. Palsy has the consequence that the vocal cords may not acquire the normal 
phonation position [129]. This leads to hoarseness and possibly difficulty breathing if 
the nerves are damaged on both sides [5]. Following insufficient glottis closure the air 
used during phonation is used quicker with consequently short phonation time from 
one expiration. One may also having difficulty lifting heavily, as one cannot keep the 
air trapped in the lungs in order to stabilize the torso during such physical efforts 
[132]. 
The RLN follows a circuitous route, arising from the vagus nerve in the upper 
mediastinum and then ascending to the larynx in the tracheoesophageal groove. On 
the right side the nerve curves around the subclavian artery. On the left side the nerve 
curves around the aortic arch [3]. The RLN is located close to the thyroid gland [129] 
and is therefore vulnerable to surgical damage both in the thoracic cavity and around 
the thyroid gland [133, 134].  
Diseases such as thyroid cancer, diseases in oesophagus, aorta aneurisms, respiratory 
tract diseases and lymph node diseases may all affect the function of the nerve. Vocal 
cord palsy may also be caused by inflammation of the nerve, or a trauma to the nerve 
as a consequence of, for example, an accident. If the cause for RLN palsy remain not 
specifically determined the condition is denominated Idiopathic RLN palsy [135]. 
 
Laryngitis 
Laryngitis is a collective term for inflammation in the larynx and vocal cords [5]. The 
inflammation is often caused by a bacterial or viral infection associated with colds or 
sore throats [136], but can also be due to allergies [137], voice overload [138] and 
 41 
smoking [139]. The main symptom of laryngitis in adults is hoarseness or loss of 
voice, regardless of aetiology. The condition may be acute or chronic [5].  
 
7.5.2 Functional voice disorders 
Functional voice disorders are a heterogeneous group of conditions that can be 
divided into several subgroups e.g. psychogenic voice disorder (PVD) and hyper-
functional or muscle tension voice disorder (MTVD) [108]. In clinical practise 
functional voice disorders are often related to “improper” use of the larynx and vocal 
folds in order to produce voice. This can cause tension in the (intrinsic) muscles 
involved in vocal folds movements or (extrinsic) muscles around the larynx, 
regulating the positioning of the larynx. The voice may be affected through excessive 
use, for example in professional use or through communication in noisy 
environments. Extensive clearing and coughing can also affect the voice [9, 107]. 
Psychogenic causes like stress or emotional factors are recognized to affect the voice 
and may cause a voice problem to develop or worsen [9, 108, 140]. 
The term Muscle Tension Dysphonia (MTD), first used by Morrison, Nichol and 
Rammage [141] has been used to describe those voice disorders resulting from 
laryngeal muscle hyper-function without structural changes to the vocal folds. Its 
onset could be sudden i.e. when cheering at a sporting event, or gradual i.e. 
developing over the course of months or years. MTD could occur following an upper 
airway infection, or as part of one’s unique personality. It can affect pitch, loudness 
and quality or a single component of voice. It could result in aphonia when the tense 
folds are abducted or dysphonia when they are adducted. It may be disabling to the 
speaker or merely a nuisance. It can be further aggravated by medical conditions or 
develop as a compensatory response to another underlying problem. In short, the 
speaker is incorrectly using muscles for voice production, causing changes in the 
acoustic signal and sensory complaints. Common causes of MTD are overuse, i.e. 
abuse, and misuse of the larynx and vocal folds. Various medications, chronic 
medical conditions, i.e. reflux, and ongoing exposure to irritants contribute to the 
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problem, as do changes in emotional and physical health. The most common voice 
characteristics are roughness, breathiness and strain, with accompanying pitch and 
phonation breaks, and hard glottal attacks. Phonation range may be reduced or show 
evidence of a break. Complaints of vocal fatigue, throat irritation and dryness, and an 
increased desire to clear the throat are frequent. Likewise, visible and palpable signs 
and symptoms of excessive musculoskeletal tension in the upper torso and larynx 
may be present. Voice therapy may be effective in reducing or eliminating MTD. 
Length of treatment varies widely, with gradual onset, long-standing MDT usually 
requires more therapy than sudden-onset aphonia or dysphonia [142]. 
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8. AIMS OF PRESENT STUDIES 
 
I To document a Norwegian translation of the Voice Handicap Index (VHI), 
evaluate reliability and validity of the VHI-30N, and to investigate whether a 
shortened VHI questionnaire can be recommended. 
 
II To investigate in a multicenter setting the ability of the VHI to discriminate 
between different voice diseases, the psychometrics of VHI dependent on 
specific voice disease and the influence the exact voice diseases regarding best 
VHI cut-off values between the healthy and diseased. 
 
III To investigate HRQoL among patients with voice disease and to study the 
relation between HRQoL and present neuroticism. 
 
IV To further document the importance of acoustic voice analyses and maximum 
phonation time measures into clinical investigations. 
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9. STUDY DESIGN, SUBJECTS AND 
METHODOLOGY 
9.1 Design 
This thesis is based on an observational combined cross-sectional and case-control 
survey design using quantitative methodology. The study included standardized 
clinical tests by examination of patients in conjunction with outpatient visit. Patients 
were interviewed and informed individually by one researcher during the 
consultations and answered questionnaires in equal manners afterwards. The study 
was conducted by using self-reporting questionnaires that had been translated into 
Norwegian language and used in previous studies [90, 143, 144]. 
9.2 Etichs 
The ethical guidelines of the Helsinki Declaration (World Medical Association, 2000) 
form the ethical basis of this work. The Regional Committee for Medical and Health 
Research Ethics, Western Norway (REK-Vest), approved the project. Written 
informed consent was obtained from all participating patients and controls, and they 
were informed they could withdraw from the study at any time, without any 
consequences. They were given the opportunity to ask questions about the study and 
their participation at any time by contacting the project leader. Anonymity was 
ensured and the data securely stored. 
9.3 Subjects 
Subjects from 7 different cohorts have been included in the 4 studies of this thesis.  
The total number of patients are 555, of these 459 had at the time of inclusion 
medical conditions recognized to affect the voice, or they were previously treated for 
such conditions. Among these were 104 laryngectomies. Former HNSCC (96) 
patients may have altered voice function due to location of disease (larynx) or 
treatment (i.e. surgery or radiotherapy) of disease in other locations.  
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In total 232 controls were included in two different cohorts to match patients included 
in paper 1, 2 and 4 (see table below). Finally in paper 3 answers to PROM from 1956 
randomly selected citizens of Norway were included as controls.  
Cohorts used in different papers: 
Cohorts Paper 1 Paper 2 Paper 3 Paper 4 
IA x x   
IB x x   
I/II  x x x 
HUH/HNCC   x  
GNR   x  
NLS   x  
HUH/control    x 
 
Cohort IA: Controls (N=126) used in paper I and II 
Cohort IB: Patients (N=126) used in paper I and II 
Cohort I/II: Patients (N=229) used in paper II, III and IV 
Cohort (HUH/ HNSCC): Former HNCC Patients (N=96) used in paper III 
General Norwegian references (GNR): Control (N=1956) used in paper III 
Cohort of National Norwegian Laryngectomies (NLS) (N=104) used in paper III 
Cohort (HUH/control): Controls (no-voiced disorders) (N=106) used in paper IV 
 
Paper # 1 
This study consists of two cohorts: 
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Controls, also Cohort IA in paper #2.  
The control group (N=126) consisted of 29 men (median age 53, range 20-68) and 97 
women (median age 46, range 19-66) who were recruited among psychology 
students, primary school teachers, special educational needs teachers, consultants, 
secretaries and speech-language therapists. Participants in the control group were 
anonymous and the included did not receive any compensation for their participation. 
 
Patients, also Cohort IB in paper #2. 
A total of 126 adult patients participated in the study: 35 men (median age 49, range 
29-83) and 91 women (median age 44, range 18-77). The patients were examined and 
assessed for voice diseases for the first time in one of two centers: the Norwegian 
Support System for Special Education, Statped Vest in Bergen or Statped Sør-øst in 
Oslo. 
Some patients included in the study were self-referred; others were referred via the 
Pedagogical- Psychological Service. The patients originated from most areas of 
Norway. All patients were examined by an ENT specialist, and the diagnosis they 
received was reported by the patients when included in the study. Both patients and 
controls signed consent forms before they were included in the study. 
 
Paper # 2 
This study consists of three cohorts: 
 
Cohort IA (controls) and Cohort IB (patients) as in paper # 1. 
 
Cohort II (patients), also Cohort I in paper # 3 and paper # 4. 
The participants (N = 229) consisted of 138 men [median age 61 years (range 24–86 
years)] and 91 women [median age 51 years (range 18–79 years)], and were included 
consecutively following consultations at the laryngology clinic in HUH when studied, 
including stroboscopic investigation of the vocal folds. Patients with benign disease 
were included before specific therapy was initiated. The dysplasia and cancer patients 
were included at follow-up after completion of primary therapy. The patients were 
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required to answer intelligibly to written questions in Norwegian in order to be 
included. 
 
Paper # 3 
This study consists of four cohorts: 
I: Cohort of Haukeland University Hospital (HUH) patients 
with voice disease, also Cohort II of paper # 2 and Cohort I of paper # 4. 
 
II: General Norwegian reference 
A randomly selected sample of 3000 people, reflecting the age and gender 
distribution of the adult Norwegian population, was obtained by a random draw from 
the adult Norwegian population. Of the 3000 invited, 1956 returned the questionnaire 
and were available for analyses. The EORTC QLQ-C30 (version 2.0) and a 
questionnaire about demographic data and health were mailed. Detailed information 
about these reference HRQoL data has been published previously [145, 146].  
 
III: Cohort of patients from HUH formerly treated for head and neck squamous cell 
carcinoma (HNSCC) 
This group included 96 successfully treated patients with HNSCC from western 
Norway aged less than 80 years who were primarily treated at HUH. HRQoL data 
were collected a median of 4 years after the primary diagnosis of HNSCC. The 
patients with HNSCC responded to the questionnaires by structured interviews. The 
patient, tumor, and therapy characteristics have been published previously [144].  
IV: Cohort of National Norwegian Laryngectomies (NLS) 
All patients with laryngectomy in Norway become members of the NLS, a subsidiary 
of the Norwegian Cancer Society. Copies of EORTC QLQ-C30 (version 3.0) were 
mailed to all registered members of the NLS below 80 years of age. A second 
invitation was mailed if the patients did not respond to the first. In total, 104 patients 
answered the questionnaires, and the specific data have been published previously 




Paper # 4 
Cohort (cohort I) of Haukeland University Hospital (HUH) patients with voice 
disease. 
Control group (HUH/control) 
The control group consisted of 106 volunteers recruited by information posters and 
letters distributed to employees and students at the hospital and university. The 
inclusion criteria were that a signed informed consent, age above 18 years, a video-
laryngo-stroboscopy, and a successfully recorded voice sample and answered the 
VHI questionnaire. Furthermore, cognitive functions and language skill needed to 
answer the VHI questionnaire intelligible were required. If the controls were 
diagnosed with larynx pathology at the video-laryngo-stroboscopy they were 
excluded from the study. Eight participants were excluded either due to findings of 
pathology in their larynx, did not complete the examination or had missing 
parameters in the VHI questionnaire. This constitutes 8.5 % dropout, and a total of 98 
participants were included in the study, median age 34 year and range 19-74 years. 
Thirty-tree males, median age 32 year, range 19-63 years, and 65 women, median age 
35 year, range 22-74 years were included. 
9.4 Methods 
In paper I the diagnostic was based on an ENT examination of the patients before 
referral to speech therapy.  
In paper II-IV the diagnostic procedures of each patients were based on clinical 
examination with both speech therapist and laryngologist. The video-recordings 
(from VLSS) were analyzed systematically according to methods modified from 
those described by Hirano and Bless [16]. The mobility of vocal folds and glottic 
waves were noted and any pathological conditions in the laryngeal mucosa i.e. causes 
of organic voice disorders were described.  
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The speech therapist could assess the voice quality by listening to the voice both 
during examinations and voice recordings.   
Voice recordings were performed with each patients sitting in a small sound-proof 
room to reduce noise disturbances. The recordings were standardized by a fixed 
distance from mouth to microphone (40 cm). The patient read a standard text from a 
Fable, including a sustained vowel (a) as long as the patient`s breath could maintain.  
The voice recordings were stored in separate files for further analysis. Acoustic 
analyses were performed with soft-ware delivered by Key-Elemetrics (USA). 
Selected acoustic parameters; Fundamental frequency, Shimmer, Jitter, Noise to 
harmonics ratio were measured. 
The maximum phonation time could be measured from the voice recordings and 
used as a substitute for respiratory function tests or “aerodynamic” examination.  
 
Each patient was given a handout with standardized questionnaires including 
Patient Related outcome measures (PROM) in order to assess the significance of 
the voice-problem for the individual patient. For more details see appendix.  
 
9.5 Statistical analyses 
Statistical significance was considered if p<0.05. All p-values reported represent two-
sided tests for all four papers.  
Paper # 1 
Chi square, correlation analyses, and Receiver Operating Characteristic (ROC) 
analyses were employed as indicated. The VHI-30, as well as the abbreviated scales 




Paper # 2 
Cronbach’s alphas, analysis of variance ANOVA analyses followed by Bonferroni 
post hoc method, as well as percentiles were calculated as indicated. In particular, the 
post hoc part of the ANOVA analyses was used to discriminate between various 
laryngological disease group scores as recommended by Holm and Christman [22]. 
 
Paper # 3 
Cronbach alpha, Pearson correlation, partial correlation, and multivariate analysis of 
variance (MANOVA) analyses followed by post hoc Bonferroni method were 
calculated as indicated. 
 
Paper # 4 
Cronbach alpha, Pearson correlation, linear regression analysis and Multiple Analysis 
of Variance (M) ANOVA analyses followed by post hoc tests (Bonferroni method) 




10. RESULTS AND SYNOPSIS OF PAPERS 
10.1 Paper  # 1 
The aims of the first study was to examine the psychometric properties of a 
Norwegian translation of the Voice Handicap Index (VHI) and test its ability to 
discriminate between patients and controls. In addition, potential abbreviated versions 
of VHI were studied. Following standard translation, 126 healthy subjects and 126 
patients with laryngeal disease answered the Norwegian translation of the VHI-30 
(hereafter, VHI-30(N)). The VHI(N) showed a high Cronbach’s alpha. One three-
level question where the subjects rated level of voice disease correlated well with the 
VHI(N) scores. Differences between patient and control groups were significant for 
all questions of the VHI(N). Receiver Operating Characteristic (ROC) analyses 
demonstrate that the Functional, Physical, Emotional and total VHI scores 
discriminated very well between patients and controls. Good discrimination was also 
found when analyzed the abbreviated scales as published by Nawka et al and Rosen 
et al. This Norwegian version of the VHI questionnaire seems to be psychometrically 
sound. 
 
10.2 Paper # 2 
The aim of this study was to determine to what extent the Voice Handicap Index-
Norwegian (VHI-N) was scored depending on specific laryngological diseases. In a 
multi-center study, 126 healthy subjects and 355 patients with different voice-related 
diseases answered the VHI-N. The VHI-N scores showed high Cronbach’s alpha. 
Analyses of variance were performed with VHI-N dependent and specific voice-
related disease as independent variable, and showed highly significant dependence by 
group allocation. When studying post hoc analyses secondary to this ANOVA 
analysis, we have shown that the control group scored lower than the entire patient 
groups except the dysplasia group. Aphonic patients scored worse than all the other 
groups except those with spasmodic dysphonia. The cancer patient group furthermore 
 52
scored better than patient groups with recurrent palsy, dysfunctional disease and 
spasmodic dysphonia. In addition, patients with recurrent palsy scored worse than 
patients with degenerative/inflammatory disease. No influences of patient age, 
gender, or smoking were observed in the VHI-N scores. The VHI-N is a 
psychometrically well-functioning instrument, also at disease-specific levels and 
discriminates well between health and voice diseases, as well as to some extent 
between different voice-related diseases. The VHI-N may also be recommended to be 
studied when monitoring voice-related disease treatment. 
10.3 Paper # 3 
The third study aimed to document the importance of including general HRQoL 
measures to clinical voice disease investigations. The participants (N = 80 larynx 
cancer, N = 32 recurrent palsy, N = 23 dysfunctional, N = 75 
degenerative/inflammation, N = 19 various), were included consecutively at the 
laryngology clinic at Haukeland University Hospital. In addition, HRQoL data was 
included from a national group of laryngectomy patients (N = 105), from a group of 
former HNSCC patients (N = 96), and from a population-based reference group (N = 
1956). Obtained were the European Organization for Research and Treatment of 
Cancer Core Quality of Life Questionnaire (EORTC QLQ), the Voice Handicap 
Index (VHI), as well as the Eysenck Personality Inventory (EPI) neuroticism scores 
from the patients group with patients with specific voice disease. By analysis of 
variance, we have determined significant dependence of groups analyzing the sum 
global QoL/health index, the functional HRQoL sum score, and the symptom sum 
HRQoL scores. In particular, patients with recurrent palsy and laryngeal cancer had 
lowered HRQoL. At the index levels, in particular dyspnea scores, were scored 
depending on larynx disease group. The VHI score correlated with the EORTC 
H&N35 “speech” index with a common variance of 52%. VHI scores correlated with 
level of neuroticism with 8% common variance and EORTC scores with 22%. Our 
conclusion was, in particular, among patients with voice-related disease, those with 
recurrent palsy and laryngeal cancer had lower HRQoL. Furthermore, the HRQoL 
 53 
and VHI scores were inversely tied to neuroticism among the patients in the specific 
voice disease group. 
 
 
10.4 Paper # 4 
The fourth study aims to investigate the relationship between aerodynamic 
measurements, acoustic measurements from voice analyzes and VHI-30N, and 
further documenting the importance of acoustic voice analyses and maximum 
phonation time measures into clinical investigations. : The participants (N= 80 larynx 
cancer, N=32 recurrent palsy, N=23 dysfunctional, N=75 degenerative/inflammation, 
N=19 various) were included consecutively at the outpatient laryngology clinic at 
Haukeland University Hospital. In addition, a control group of 98 healthy subjects 
were included. Obtained were voice samples, maximum phonation times (MPT) and 
the Voice handicap index (VHI) scores in addition to standard clinical information. 
Acoustic analyses were performed from these samples determining level of jitter, 
shimmer and noise to harmonic ratio (NHR) as well as analyzing frequency of a 
prolonged vowel. The maximum phonation time was also measured. 
We found Jitter, shimmer and NHR scores correlated strongly to each other. By 
ANOVA analyses, we have determined significant dependence on diagnostic group 
analyzing all the obtained acoustic scores. All patient groups but the dysfunctional 
group scored to some extent differently from the control group. In addition, jitter 
scores differed between dysfunction and recurrent palsy and shimmer score differed 
between dysfunctional and cancer group. Regarding NHR the cancer patients scored 
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higher than the degenerative/ inflammatory group. Dependent on MPT, the cancer 
group scored higher than the degenerative/inflammatory and recurrent palsy groups.  
Among larynx disease patients acoustic and MPT analyses segregated with all 
determined analyses between patients and control conditions except the dysfunctional 
group, but also to some extent between various patient groups. VHI scores correlated 
to jitter, shimmer and NHR scores among cancer and degenerative/inflammatory 
disease patients. Acoustic analyses potentially add information useful to 
laryngological patient studies. 
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11. DISCUSSION 
Methodological considerations concerning strengths and limitations 
Inclusions:  
Inclusions in general: Ideally the inclusion criteria should have been identical 
throughout all studies of this thesis and more patients should have been included in 
order to obtain a better differentiation between specific diagnoses. Still, the total 
numbers of patients sums up to a total of 555 and the controls to a total of 2188 
which are substantial numbers. These large numbers provided information as to 
voice function and QoL and provided information for comparison between 
cohorts in a matter that would have been difficult to achieve with less patients.  
Controls: Three different control groups were used in the four studies included in this 
thesis as shown in the table in chapter 9.3. In paper I and II the 126 controls were 
recruited mainly among students and teachers. The controls reported no voice disease 
and the voices were also controlled by speech therapists using perceptual voice 
assessment as method. The patient and control groups were well matched regarding 
gender and age in study I. It is regarded as strength of these two studies that the 
controls were thoroughly selected, but ideally controls should have been matched 
towards patients also in study II.  
The references (GNR) in study III have previously been published by Hjermstad 
and co-workers [145], who examined the HR-QoL in general Norwegian 
population. The reference group (GNR) consisted of 1956 answers (EORTC 
QLQ 30) from 3000 invited subjects randomly drawn from the Norwegian 
population including subjects from 18 to 93 years of age. The questionnaires 
included questions regarding speech, experience of voice disease as well as level 
of voice use at home and at work. It is valuable to have information as to these 
voice related health questions from such a large representative group of the 
population.  
The controls of study IV were 98 volunteers recruited at the hospital (HUS). 
They were between 22 and 74 years of age (median 34 years) and thus younger 
than the patients (median 51, range 18-79). It is possible that older controls, e.g. 
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patients with non-laryngeal diseases, would have matched the patients better. 
Interestingly, the patient group with dysfunctional disease scored similar to the 
control group indicating that in the limited sense of acoustic variables this group 
may be viewed a “control” group adding support to the actually denominated 
control group the age difference is not of any major importance. 
 
Patients: The 126 patients from cohort 1B used in study I and II were included after 
examination by ENT physician and referred to assessment for speech therapy. The 
design of the first two studies could have been improved if the diagnoses had been 
obtained from an ENT examination for all patients and not from reports of the 
patients.  
The cohort I/II used in study II, III and IV consisted of 229 patients that were 
included consecutively after examination by laryngologist and speech therapist. The 
thorough examination by two specialists and precise diagnostic procedures 
including high return-rate (81 %) are recognized as strengths of these studies 
concerning data from this cohort. This also involves cohort HUH/HNSCC 
consisting of 96 patients successfully treated for HNSCC included in study III.  
The cohort of NLS used in paper III consisted of 104 patients and has been included 
in a former study by Birkhaug and colleagues (2002). This was a relatively 
homogenous group of patients as the majority of them were laryngectomized due to 
laryngeal cancer.  
 
Diagnostic categories:  
When the VHI total score was analyzed in the third study patients were grouped 
according to specifically clustered larynx diseases [148]. This was done based on a 
method suggested by Verdonck- de Leeuw et al [42] and Nawka et al [41].  
The most versatile group of these was degenerative/ inflammatory and 
dysfunctional; including dysplasia, laryngitis and papilloma subsequently merged 
with Reinke edema, polyps and cysts as shown in figure 2 and table 2 in paper III. It 
can be discussed whether important information is lost when diagnostic groups are 
allocated in categories, and not presented as strictly separated clinical entities. Still, 
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from a clinical view it is interesting to note that 95% CI VHI total score (fig. 2 
paper III) show such a linear increase from controls (lowest) to aphonia (highest), 
with cancer patients at the lower part compared to the other disease groups. This is 
an intriguing observation as one would expect that cancer patients should give high 
VHI scores due to such a serious disease. Most cancer patients were included after 
successful treatment of their disease which possibly have influenced their answers 
concerning voiced related problems. It is from this observation pertinent to argue 
that VHI has a disease specific QoL aspect that should be taken into account when 
used in clinical settings.   
 
Standardization of Voice analyses:  
A general problem faced by all researchers using acoustic voice analyses is the 
lack of standardization across laboratories. Computer software [149, 150], and 
the individual voice laboratory standard methods differ. This hampers the ability 
to compare results from different centers. In fact, various results may to some 
extent be caused merely by lack of standardization of the analyses. In this thesis 
all voice recordings were performed in the same location under strictly repetitive 




11.2 Discussion of the main findings of the study 
Voice Handicap index as diagnostic tool  
Abbreviated version of VHI: Several authors have suggested that the number 
of items included in the VHI could be reduced [41, 151]. This thesis has 
revealed that VHI has a strong internal consistency across different domains 
and discriminate well between patients and controls. Furthermore, an 
abbreviated version of VHI may be used as an alternative to the standard 
version. Abbreviated questionnaires revealed scores closely correlating to the 
original VHI-30, and abbreviated VHI are less time consuming and can be used in 
clinical practice and possibly also in research. 
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Disease dependent VHI score: VHI was developed in order to quantify 
perception of voice disease in general, and not primarily to separate between 
various laryngological diseases [33]. In the recent years many investigators 
have extended the scope of VHI. In fact scores may depend on disease-groups 
as shown also in this thesis. A grading of six disease-related scoring levels 
from low to high is suggested for VHI-N. Lowest scores were obtained with 
voice-related cancer, then structural/inflammatory larynx disease, 
dysfunctional disease, recurrent nerve disease, spasmodic dysphonia and 
finally aphonic patients.   
By comparing VHI scores from different patient-cohorts valuable 
information can be achieved as to how different diseases affect voice. But 
there are some obstacles with these comparisons. The rating of VHI scores 
and voice related diseases differs between studies. In addition splitting of 
laryngeal diseases into groups differs as well. This may be one explanation for 
various findings. Rosen et al. [152] have suggested that highest VHI scores is 
obtained from patients with unilateral vocal fold paralysis, followed by 
patients with benign vocal fold lesions. Helidoni et al. [153] and Lam et al. 
[43] have determined in their studies that the neurogenic group had the 
highest VHI scores, whereas the lowest scores occurred in the inflammatory 
group. Verdonck-de Leeuw [42] and Nawka [41] suggested larynx-diseased 
patients to be placed in five different groups having similar levels of VHI 
scores; i.e., dysfunction, nodules, structural, palsy and laryngitis reporting 
from a multi-center study based on data from many different sites across 
Europe. More studies are needed in order to sort out a more consistent 
relation between laryngeal disease and voice handicaps as measured by VHI. 
This thesis has also shown that measurements of general QoL can add 
valuable information to this relation. The voice may be a good index of the 
general state of health including mental health [1].   
 
Acoustic parameters as diagnostic tool 
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Quality of voice is difficult to assess in an objective way as stated earlier in this 
thesis. One would expect that a standardized and objective measurement of the 
specifiable parameters of voice production would be helpful. Analyses of acoustic 
parameters are therefore recommended by Dejonckere and co-workers in the ELS 
protocol [7]. This thesis has shown that objective measurements of acoustic 
parameters enables a differentiation between subjects with no voice problems and 
patients with affected voice. As could be expected the controls and patients with 
functional diseases could not be separated by analyses of acoustic parameters. The 
voice in functional diseases does not differ substantially from a normal voice.  
The parameters jitter, shimmer and NHR differentiated best between the 
laryngological diagnoses and one can therefore argue that these should be 
included in objective analyses of voice quality when used in a clinical setting. 
Interestingly jitter, shimmer, and NHR scores correlated closely as shown in this 
thesis. This is in accordance with the findings of Ziwei and allied [154]. These 
parameters thus seem to reflect a common underlying entity. It is therefore 
interesting to note that there was a 10% common variance between VHI scores 
and the acoustic variable scores among the patients; mostly among cancer and 
degenerative and inflammatory patients. 
It is well known that pitch level and pitch range of the voice depend on growth 
and aging process (Zemling 1998). Age of the patients may therefore be of 
importance as to acoustic analyses [155, 156]. This has also been shown in the 
present study regarding jitter, shimmer, and NHR.  
Prior to puberty there is little difference in pitch and range of the voice when boys 
and girls are compared. After puberty there is an anatomical difference between the 
male and female larynx resulting in a drop of the lower range of male voice with 
about one octave [1]. Therefore the influence of gender on the voice must be taken 
into account when voice parameters are measured. In this thesis acoustic 
measurement absolute values were generally scored different among males and 
females as have been shown previously [157, 158]. Adjusting by age and gender 
did however not remove significant results regarding jitter, shimmer, and MPT 
on diagnostic group measured by ANOVA analyses. Gender did on the other 
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hand influence on the significant differences concerning the F0, therefore 
separate analyses dependent on gender were conducted. Larger studies are 
needed in order to determine more conclusively the importance of age and gender 
as to acoustic analyses dependent on diagnosis. 
Studies in this thesis have shown that acoustic voice analyses reveal pathology of 
the voice when laryngeal diseases are studied on group level. The magnitude of 
voice pathology is also reflected to some extent. Analyses of jitter, shimmer and 
NHR can provide important objective information as to voice quality for example 
when treatment effects are studied. This is in accordance with observations from 
Gillespie and co-workers [159]. 
  
Patient-reported outcome measures (Prom) 
Voice disorders and quality of life aspects: 
This thesis shows that HRQoL scores may yield information when included in 
clinical routine laryngological consultations. 
Level of neuroticism is known to have a major impact on HRQoL scores in various patient 
groups [144]. Thus, it is of relevance to determine this impact when acquiring 
HRQoL of patients with larynx disease. We have shown that level of neuroticism was 
correlated to the HRQoL scores and to VHI scores with a substantial common 
variance. In addition, some of the common variance between the HRQoL and the VHI 
scores were secondary to level of neuroticism. The impact of neuroticism on the VHI 
scores in addition strengthens the view that the VHI score may be classified as a 
HRQoL score. 
Among the patients with larynx disease, the EORTC-H&N35 “speech” index in 
particular was scored with a close association to the VHI score. This suggests that the 
VHI questionnaire may be used generally in conjunction with the EORTC QLQ. This 
is especially important when the EORTC-H&N35 speech index is scored with a high 
value. 
The association between voice quality and general HRQoL suggests that voice 
patency contributes substantially to the generation of good HRQoL. Therefore voice-
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improving treatments may be used in order to generate better HRQoL among patients 
with larynx diseases.   
Patients scored HRQoL differently depending on type of laryngeal disease. Recurrent 
palsy and laryngeal cancer is associated with low general HRQoL. The low HRQoL 
of cancer patients could be expected. It is therefore interesting to notice that 
laryngectomized, who particularly must be expected to suffer from the sequels [147], 
scored similar to patients of other disease groups.  
Many patients with recurrent nerve palsy have serious diseases [160], therefore low 
HRQoL scores are not surprising. The larynx has an important a protective and 
respiratory role as valve, therefore [160] respiratory function may be reduced in these 
patients. Rosen et al [152] have accordingly found that among patients with larynx 
disease, worst VHI scores were obtained from those with unilateral vocal fold 
paralysis. Helidoni et al [153] and Lam et al [43] have shown similar findings in their 
studies. Patients with neurogenic diseases affecting the larynx had the worst VHI 
scores. The present results, together with the above mentioned studies, support that 
patients with recurrent palsy as a group suffer from reduced HRQoL. 
The low HRQoL, as well as the possibility of underlying and more serious illness in 
recurrent palsy patients indicates that thorough examination looking for causality of 
the palsy as well as treatment of this condition should be prioritized. Whether 
efficient treatment e.g. by medialization of vocal folds also improves HRQoL 
should be studied further.  
 
Clinical appliances of VHI/Prom and acoustic analyses 
The VHI-N patient scores were obtained in a setting indicating that valid VHI scores 
may be obtained in standard clinical settings. The VHI-N discriminated excellent 
between healthy and laryngological disease [54], and VHI discriminated between 
laryngological disease groups.  On the other hand, to use individual test results to 
sort between specific voice-related diseases should be done with caution. 
This thesis shows that HRQoL scores may yield information when included in 
clinical routine laryngological consultations. Some of the differences between the 
groups reached 10 HRQoL points, which is consistent with being of important 
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clinical relevance [161]. A general HRQoL questionnaire will provide additional 
information about the patient and is therefore recommended to be included as part of a 





12. CONCLUDING REMARKS AND FUTURE 
PROSPECTS 
Through this study we have shown a Norwegian version of the VHI questionnaire to 
be a psychometrically functioning instrument, also at disease-specific levels. VHI-N 
discriminates well between healthy and voice diseased, as well as between some 
voice-related diseases. Furthermore, when viewing VHI in relation to HRQoL 
measures, in particular, among patients with voice-related disease, those with 
recurrent palsy and laryngeal cancer had lower HRQoL. Furthermore, both the 
HRQoL and the VHI scores were inversely tied to neuroticism. The VHI-N and a 
general QoL questionnaire may be recommended to be used when monitoring voice-
related disease treatment. Among larynx disease patients acoustic and MPT analyses 
segregated with all performed analyses between patients and control group except the 
dysfunctional group. VHI scores correlated to jitter, shimmer and NHR scores among 
cancer and degenerative/inflammatory disease patients. Acoustic analyses potentially 
add information useful to laryngological patient studies.  
We have in this thesis performed an observational combined cross-sectional 
and case-control survey design using quantitative methodology. The patients have 
only been examined when they were included in the study, but not been followed 
over time. It would be of value to perform a similar study with a longitudinal design 
included. As always, an investigational design with many successive measuring 
points will improve the value of the data. This would e.g. have allow a firmer 
conclusion about reliability of the different measurements presently obtained. 
Of the parameters listed in the recommendation of ELS to be included in the 
laryngeal examination, we have investigated the relationship between PROMs, 
aerodynamic analysis and acoustic analysis. All patients and controls have in addition 
been examined by an ENT doctor with videolaryngostroboscopy. The result beyond 
diagnosis of videolaryngoscopy has not been included in this thesis. In the case of 
perceptual analysis, we did try to perform it with a limited number of patients and 
controls, but we were not successful.  
 64
Ideally, quantitative measurements about the voice quality obtained from the 
laryngoscopic investigations have a potential to improve the knowledge of the 
actual state of larynx. No such sensitive scores has been generally accepted. Such a 
score should be developed, e.g. in line with the development of the CLE scoring 
scheme as published previously by our group [162]. Computer-assisted analysis of 
vocal cord movement with the aid of stroboscopic light during phonation may also 
improve the results obtained from investigation as the one presently reported. 
Laryngeal electromyography during phonation may also hold promises to 
contribute to voice investigation as has been shown especially concerning vocal 
cord paralysis [163].  
 
As stated above, we did not from acoustic analyses using the GRBAS form [164, 
165] obtain results that gave meaningful results when included into formal 
statistical analyses. To develop this concept further into a useable concept that 
could be included to studies like the present may improve the quality of future 
studies like the ones presently reported. Therefore, it should be a future aim of 
similar investigations as the one presently performed with addition of clinician-
based voice analyses.  
 
Obviously, the studies often improve in quality by using multicenter approach 
during data acquisition. Preferably, this should also have been done using patients 
with different mother tongue languages. To investigate this would have improved 
the quality of the conclusions of the study. 
 
We have used the EORTC QLQ out of many choices as the HRQoL general 
questionnaire. It is possible that other such questionnaires could have given other 
conclusions as to QoL of the included subjects. A more thorough personality test, 
like the MMPI, than the presently used could also have generated a more faceted 
picture of how the QoL may be generated in laryngology patients.  
 
Design-wise an experimental treatment study including the present measurements 
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could bring valuable information about the instruments presently used. To study the 
investigated parameters in a treatment frame where the patients were scored before 
and after a specific treatment would obviously have improved the validity of the 
results [165, 166]. Several investigators have tried this. Ohlsson and allied did a 
randomized clinical trial to study the voice therapy outcome, i.e. measured by VHI, 
comparing individual therapy, group therapy and no therapy [167]. They showed an 
improved VHI score following voice therapy, as well as improved voice quality as 
measured by speech language therapists. The study included randomization to 
different treatments, but the study was not blinded. Abrahamsson and allied have 
reported measured effect of voice therapy by VHI pre-post intervention on group 
and individual therapy and found improvement [168]. This illustrates that high 
quality studies are performed and published concerning treatment of vocal cord 
disorders with e.g. voice therapy. To add acoustic voice analyses to such studies 
would help to circumvent the challenge with eliminating placebo effects from such 
results.  
 
Professional use of voice as e.g. with singers represents an interesting area of 
research, in particular when larynx-related disease affects such patients. To use 
systematically a formal battery of tests like presently performed in such situation 
could both answer more about validity of the ELS design currently investigated, 
and possibly show an area where a more systematic approach concerning voice 
patients could be useful [169]. 
 
One interesting option is to use instant biofeedback from both laryngoscopic 
examination and/or acoustic analyses as learning help for patients with mal-
functioning vocal box. The patient could focus on generating as little shimmer as 
possible, or generating a smooth stroboscopic vocal cord wave without actually be 
given any extra information. If successfully, this could be another example of useful 
clinical biofeedback [170]. 
Several of the disease groups included to the present study could have been studied in 
more detail. In particular, this holds true with the patients with laryngeal cancer. The 
 66
question about voice quality following cancer surgery compared to radiation therapy 
when treating patients with limited laryngeal cancer is still controversial and still 
needs input of knowledge [171].  
In any case, we have studied voice investigation tools that may be included to the 
voice analysis tool box, but this subject matter still needs to be more studied. One 
present main focus has been to validate the suggested voice investigation strategy as 
originally suggested by ELS [10], and it is supported that QoL scores and acoustic 
analyses at group level may be included to standard voice studies. Future studies, 
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Questionnaires employed in the study: 
- Demographic data 
- Voice Handicap Index (VHI) 
- EORTC QoQ-30 
- H&N-35 
- Eysenck Personality Inventory (EPI)  
 
Tables:  

















Hvordan opplever du din stemmevanske? 
 
- Sett kun ett kryss ved svaralternativet som passer deg og skriv der det er nødvendig - 
___________________________________________________________________________ 
 




3. Når oppstod stemmevanskene dine? 
     Prøv å angi omtrent årstall: ______________ 
 
4. Angi med en strek på skalaen nedenfor i hvilken grad du opplever ditt 
stemmeproblem. 
 
Ingen plager _________________________________________________________________ Uutholdelige 
 plager 
    
5. Hvor ofte opplever du stemmeproblemene? 
 
□ hver dag      
□ ukentlig 
□ annenhver uke 
□ en gang i måneden 
□ annenhver måned 
□ et par ganger i året 
 
6. Hvor mye bruker du din stemme på jobb? 
 
□ jobber ikke  
□ nesten ingenting (snakket lite) 
□ noe (eks. kontor, mye data osv.) 
□ normalt (eks. samtale med kollegaer, noen telefoner osv.) 
□ mye (eks. en del telefoner, møtevirksomhet, noe undervisning osv.) 
□ svært mye (eks. undervisning, foredrag, telefoner osv.) 
 
7. Hvor mye bruker du din stemme i fritiden? 
 
□ nesten ingenting (snakket lite i sosiale sammenhenger) 
□ noe (når jeg måtte, når jeg var ute og handlet og lign.) 
□ normalt (snakket med familie og venner) 
□ mye (likte å prate/være sosial, interesser som krevde 
stemmebruk) 





8. Hvilke tiltak/behandling er satt inn for å bedre stemmevanskene? 
 
□ Ingen 
□ Kirurgisk inngrep/operasjon 
□ Logoped behandling 
□ Kirurgi og logoped 
 
9. Hvilke tiltak har du gjort for å bedre din stemme (sett mer enn ett kryss om nødvendig)? 
 
□ Ikke gjort noe 
□ Har skiftet yrke/måtte endre arbeidsoppgaver på grunn av 
stemmen 
□ Redusert egen stemmebruk 
□ Unngår å bruke stemmen 
□ Gjør ofte ”stemmeøvelser”  
□ Er bevist på hvordan jeg bruker stemmen 
    
Annet: _______________________ 
 
10. Hva føler du har gitt størst bedring på stemmen din? 
 
□ Ingenting 
□ Kirurgi/operasjon  
□ Logopedisk behandling 
□ Kirurgi og logoped  





11. Røyking? (Det er veldig viktig at du svarer så korrekt som mulig. Om du aldri har røykt, så 
svarer du ikke her. 
 
▪ Antall sigaretter pr dag nå: ____ 
 
▪ Antall sigaretter pr. dag før (om du har redusert/sluttet):______ 
 
▪ Antall år du har røykt, totalt: _____   
 
▪ Hvis du har sluttet å røyke, i så fall hvilket år? _____   
 
 
12. Hvilket yrke har du/har du hatt før:__________________________________ 
 




14. Kryss av ved de plagene i skjemaet under som eventuelt gjelder for deg nå. 
 
Slim i halsen:     
□ ingen plager 
□ litt plaget 
□ plaget 





Tørrhet i halsen: 
□ ingen plager 
□ litt plaget 
□ plaget 
□ meget plaget 
□ uutholdelig plaget 
 
Tretthet i halsen: 
□ ingen plager 
□ litt plaget 
□ plaget 





□ ingen plager 
□ litt plaget 
□ plaget 
□ meget plaget 
□ uutholdelig plaget 
 
Smerter i halsen: 
□ ingen plager 
□ litt plaget 
□ plaget 





□ ingen plager 
□ litt plaget 
□ hes stemme 
□ meget hes  
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VOICE HANDICAP INDEX  (VHI) 
 
 
Instruksjon: Dette er utsagn som mange personer har brukt for å beskrive stemmen sin og 
hvilken innvirkning den har på livet deres.  Sett ring rundt svaret som viser hvor ofte du har 











1. Stemmen min gjør at det er vanskelig 
for folk å høre meg. 
0 1 2 3 4 
2. Jeg går tom for luft når jeg snakker.  0 1 2 3 4 
3. Folk har vanskelig for å forstå meg i et 
rom med støy.  
0 1 2 3 4 
4. Stemmen min varierer i løpet av 
dagen.  
0 1 2 3 4 
5. Familien min har problemer med å 
høre meg når jeg roper på dem fra 
forskjellige steder i huset.  
0 1 2 3 4 
6. Jeg bruker telefonen sjeldnere enn jeg 
har behov for.  
0 1 2 3 4 
7. På grunn av stemmen er jeg anspent 
når jeg snakker.  
0 1 2 3 4 
8. Jeg har lett for å unngå grupper av 
mennesker p.g.a stemmen min.  
0 1 2 3 4 
9. Det synes som om folk irriterer seg 
over stemmen min.  
0 1 2 3 4 
10. Folk spør: ”Hva er i veien med 
stemmen din ?”  
0 1 2 3 4 
11. Jeg snakker mindre med venner, 
naboer eller slektninger p.g.a. 
stemmen min. 
0 1 2 3 4 
12. Folk ber meg gjenta det jeg sier når 
jeg snakker med dem ansikt til ansikt.     
0 1 2 3 4 
13. Stemmen min høres sprukken og tørr 
ut. 
0 1 2 3 4 
 
 Fra Jacobson et. al. (1997). The Voice Handicap Index (VHI). American Journal of Speech-Language Pathology 6. 
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14. Jeg føler at jeg må presse stemmen for 
å lage lyd. 
0 1 2 3 4 
15. Folk har liten forståelse for 
stemmeproblemene mine. 
0 1 2 3 4 
16. Stemmevanskene mine begrenser 
privat og sosialt liv. 
0 1 2 3 4 
17. Klarheten i stemmen min er vanskelig 
å forutsi.  
0 1 2 3 4 
18. Jeg prøver å forandre stemmen min 
for å høre annerledes ut.  
0 1 2 3 4 
19. Jeg føler jeg blir holdt utenfor i 
samtaler p.g.a. stemmen min.  
0 1 2 3 4 
20. Jeg anstrenger meg ganske mye for å 
snakke. 
0 1 2 3 4 
21. Stemmen min er verre om kvelden. 0 1 2 3 4 
22. Stemmeproblemene mine er årsak til 
at jeg mister inntekt. 
0 1 2 3 4 
23. Jeg blir stresset av stemmen min. 0 1 2 3 4 
24. Jeg går mindre ut p.g.a. 
stemmeproblemene mine.  
0 1 2 3 4 
25. Stemmen min får meg til å føle meg 
handikappet. 
0 1 2 3 4 
26. Stemmen min svikter midt i en 
samtale. 
0 1 2 3 4 
27. Jeg blir irritert når folk ber meg om å 
gjenta. 
0 1 2 3 4 
28. Jeg føler meg flau når folk ber meg 
om å gjenta. 
0 1 2 3 4 
29. Stemmen min får meg til å føle meg 
utilstrekkelig. 
0 1 2 3 4 
30. Jeg skammer meg over 
stemmeproblemene mine. 





EORTC QLQ-C30 (versjon 3.0) 
 
Vi er interessert i forhold vedrørende deg og din helse. Vær så vennlig å 
besvar hvert spørsmål ved å sette en ring rundt det tallet som best 
beskriver din tilstand. Det er ingen ‘riktige’ eller ‘gale’ svar. Alle 
opplysninger vil bli behandlet konfidensielt. 
 
 
       
              Ikke i det   En         Svært 
                  hele tatt    Litt del          mye    
1.  Har du vanskeligheter med å utføre anstrengende 
      aktiviteter, slik som å bære en tung handlekurv eller en koffert? 1 2 3   4 
 
2.   Har du vanskeligheter med å gå en lang tur? 1 2 3 4 
  
3.   Har du vanskeligheter med å gå en kort tur utendørs?  1   2 3   4 
 
4.   Er du nødt til å ligge til sengs eller sitte i en stol i løpet av dagen?  1 2 3 4 
 
5.   Trenger du hjelp til å spise, kle på deg, vaske deg eller gå på  1            2             3          4 
      toalettet? 
 
I løpet av den siste uka:          Ikke i det  En          Svært 
              hele tatt Litt del            mye
   
 
6.   Har du hatt redusert evne til å arbeide eller utføre andre daglige   1 2 3 4           
      aktiviteter? 
 
7.   Har du hatt redusert evne til å utføre dine hobbyer eller andre 
      fritidsaktiviteter?  1 2 3 4  
 
8.   Har du vært tungpusten? 1  2 3 4 
 
9.   Har du hatt smerter? 1 2 3 4 
 
10. Har du hatt behov for å hvile? 1 2 3 4 
  
11. Har du hatt søvnproblemer? 1 2 3 4 
 
12. Har du følt deg slapp? 1 2 3 4 
 
13. Har du hatt dårlig matlyst? 1 2 3 4 
 
14. Har du vært kvalm? 1 2 3 4 
 




16. Har du hatt treg mage? 1 2 3 4 
 
17. Har du hatt løs mage? 1 2 3 4 
 
18. Har du følt deg trett? 1 2 3 4 
 
19. Har smerter påvirket dine daglige aktiviteter? 1 2 3 4 
 
20. Har du hatt problemer med å konsentrere deg, f.eks med å  
      lese en avis eller se på TV? 1 2 3 4 
 
21. Har du følt deg anspent? 1 2 3 4 
 
22. Har du vært engstelig? 1 2 3 4 
 
23. Har du følt deg irritabel? 1 2 3 4 
 
24. Har du følt deg deprimert? 1 2 3 4 
 
25. Har du hatt problemer med å huske ting? 1 2 3 4  
 
26. Har din fysiske tilstand eller medisinske behandling 
      påvirket ditt familieliv? 1 2 3 4  
 
27. Har din fysiske tilstand eller medisinske behandling 
      påvirket dine sosiale aktiviteter? 1 2 3 4 
 
28. Har din fysiske tilstand eller medisinske behandling 
      gitt deg økonomiske problemer? 1 2 3 4 
 
Som svar på de neste spørsmålene sett en ring rundt det tallet fra 1 til 7 som 
best beskriver din tilstand 
 
29. Hvordan har din helse vært i løpet av den siste uka? 
       
 1 2 3 4 5 6           7  
      
      Svært          Helt   
      dårlig         utmerket 
 
 
30. Hvordan har livskvaliteten din vært i løpet av den siste uka? 
 
         1                 2 3 4 5 6            7  
 
      Svært          Helt   





EORTC QLQ - H&N35 
 
En del pasienter opplever av og til at de har noen av de følgende symptomer eller 
problemer. Vær vennlig å angi i hvilken grad du har hatt disse symptomene eller 




I løpet av den siste uka:                                                       Ikke i det              Svært                 
        hele tatt      Litt      En del    mye 
 
31. Har du hatt smerter i munnen? 1 2 3 4 
 
32. Har du hatt smerter i kjeven? 1 2 3 4  
 
33. Har du hatt smerter i halsen? 1 2 3 4  
 
34. Har du hatt noe i vrangstrupen når du har svelget? 1 2 3 4 
 
35. Har du hatt problemer med tennene? 1 2 3 4 
 
36. Har du hatt problemer med å gape høyt? 1 2 3 4 
 
37. Har du vært tørr i munnen? 1 2 3 4 
 
38. Har du hatt seigt spytt? 1 2 3 4 
 
39. Har du hostet? 1 2 3 4 
 
40. Har du vært hes? 1 2 3 4 
 
41. Har du følt deg syk? 1 2 3 4 
 
42. Har du hatt vanskeligheter med å spise? 1 2 3 4 
 
43. Har du hatt vanskeligheter med å snakke med andre mennesker? 1 2 3 4 
 
44. Har du hatt vanskeligheter med å snakke i telefonen? 1 2 3 4 
 
45. Har du hatt vanskeligheter med å ha sosial omgang med familien? 1 2 3 4 
 
46. Har du hatt vanskeligheter med å ha sosial omgang med venner? 1 2 3 4 
 
47. Har du hatt vanskeligheter med å være ute på offentlige steder? 1 2 3 4 
 
 
I løpet av den siste uka:   Nei Ja 
 
48. Har du brukt smertestillende?   1  
 
 
”Eysenck” (EPI)        
INSTRUKSJON  
 
Dette er noen spørsmål om hvordan du vanligvis opptrer, føler og handler. 
På hvert av spørsmålene skal du enten svare ‘ja’ eller ‘nei’ ved å sette en 
ring rundt det svaret som passer best for deg. Svar så raskt som mulig, men 
avgi det svaret som er mest dekkende for din vanlige måte å være på. 
 
Det skal bare ta noen minutter å fylle ut spørreskjemaet. Pass på at du ikke 
hopper over noen av spørsmålene. 
 
Dette er ingen evneprøve og derfor er ingen svar riktig eller gale. 
 
1.  Lengter du ofte etter spenning?              JA NEI 
2.  Har du ofte behov for forståelsesfulle venner som kan  
    muntre deg opp?        JA NEI 
 
3.  Er du vanligvis uten bekymringer?      JA NEI 
 
4.  Er det vanskelig for deg å godta ‘nei’ som et svar?   JA NEI 
 
5.  Stopper du opp og tenker over tingene før du utfører dem?  JA NEI 
 
6.  Holder du alltid et løfte, uansett hvor besværlig det er  
    for deg å gjennomføre det?       JA NEI 
 
7.  Har du et vekslende humør?       JA NEI 
 
8.  Er det vanligvis slik at du sier og gjør ting raskt uten å tenke?  JA NEI 
 
9.  Føler du  deg noen ganger nedfor uten god grunn?   JA NEI 
 
10.Ville du gjøre nesten hva som helst, hvis noen utfordrer deg?  JA NEI 
 
11.Kan du plutselig føle deg sjenert når du ønsker å snakke til  
     en fremmed som du synes er tiltrekkende?    JA NEI 
 
12.Mister du en gang i blant beherskelsen og blir sint?   JA NEI 
 





14.Bekymrer du deg ofte over ting du ikke skulle ha sagt  
     eller gjort?         JA NEI 
 
15.Ville du heller lese om mennesker enn å møte dem?   JA NEI 
 
16.Blir dine følelser lett såret?       JA NEI 
 
17.Liker du å gå mye ut?        JA NEI 
 
18.Har du av og til tanker og ideer som du ikke ville like at 
     andre kjente til?        JA NEI 
 
19.Bobler du noen gang over av energi, og er du andre ganger 
     uten tiltakslyst?        JA NEI 
 
20.Foretrekker du å ha få, men utvalgte venner?    JA NEI 
 
21.Dagdrømmer du mye?       JA NEI 
 
22.Når folk bruker kjeft på deg, kjefter du da tilbake?   JA NEI 
 
23.Plages du ofte av skyldfølelse?      JA NEI 
 
24.Har du bare gode vaner?       JA NEI 
 
25.Kan du vanligvis slå deg løs og ha det morsomt i et  
     livlig selskap?         JA NEI 
 
26.Betrakter du deg selv som meget stiv og anspent?   JA NEI 
 
27.Synes andre mennesker at du er svært livlig?    JA NEI 
 
28.Når du har utført noe viktig, er det da ofte slik at du etterpå 
     synes du kunne ha gjort det bedre?     JA NEI 
 
29.Er du stort sett stille og tilbakeholden når du er sammen 
     med andre?         JA NEI 
 
30.Hender det at du driver med sladder?     JA NEI 
 





32.Hvis det er noe du ønsker å få vite, ville du heller slå opp 
     i en bok fremfor å spørre om det?      JA NEI 
 
33.Får du noen gang hjertebank?      JA NEI 
 
34.Liker du arbeid som krever intens konsentrasjon?   JA NEI 
 
35.Får du anfall hvor du rister eller skjelver?    JA NEI 
 
36.Ville du oppgi alt til tollen selv om du visste at du  
     aldri ville bli oppdaget?       JA NEI 
 
37.Misliker du å være sammen med mennesker som alltid  
     driver gjøn med hverandre?       JA NEI 
 
38.Blir du lett irritert?        JA NEI 
 
39.Liker du å gjøre ting som krever at du må handle raskt?  JA NEI 
 
40.Bekymrer du deg for at fryktelige ting skal skje?   JA NEI 
 
41.Beveger du deg sent uten hastverk?     JA NEI 
 
42.Har du noen gang kommet for sent på arbeid eller til en  
     avtale?          JA NEI 
 
43.Har du ofte mareritt om natten?      JA NEI 
 
44.Liker du så godt å snakke med noen at du aldri går glipp 
     av en anledning til å snakke med fremmede?    JA NEI 
 
45.Plages du av verking og smerter i kroppen?    JA NEI 
 
46.Ville du bli meget ulykkelig dersom du ikke det meste  
     av tiden hadde mange mennesker rundt deg?    JA NEI 
 
47.Betrakter du deg selv som en nervøs person?    JA NEI 
 
48.Kjenner du noen mennesker som du absolutt ikke liker?  JA NEI 
 





50.Blir du lett såret dersom andre finner feil med deg eller  
     ditt arbeid?         JA NEI 
 
51.Har du vanskelig for riktig å more det i et livlig selskap?  JA NEI 
 
52.Er du plaget av mindreverdighetsfølelse?    JA NEI 
 
53.Greier du vanligvis å skape liv i et heller kjedelig selskap?  JA NEI 
 
54.Hender det noen ganger at du snakker om ting du ikke har  
     greie på?          JA NEI 
 
55.Bekymrer du deg for din helse?      JA NEI 
 
56.Liker du å spille andre et puss?      JA NEI 
 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Health-related Quality of Life as Studied by EORTC QLQ
and Voice Handicap Index Among Various Patients With
Laryngeal Disease
*,†,‡Tom Karlsen, †Lorentz Sandvik, †,‡John-Helge Heimdal, §,¶Marianne Jensen Hjermstad,
†,**Anne Kari Hersvik Aarstad, and †,‡Hans Jørgen Aarstad, *†‡Bergen, §, ¶Trondheim, and **Oslo, Norway
Summary: Objectives. Patients with voice-related disorders are often treated by a multidisciplinary team includ-
ing assessment by patient-reported outcome measures. The present paper aims at documenting the importance of including
general health-related quality of life (HRQoL) measures to clinical investigations.
Study design. The participants (N = 80 larynx cancer, N = 32 recurrent palsy, N = 23 dysfunctional, N = 75 degenerative/
inflammation, N = 19 various) were included consecutively at the laryngology clinic at Haukeland University Hospital.
In addition, HRQoL data were included from one national group with laryngectomies (N = 105), one group with various
patients formerly treated for head and neck squamous cell carcinoma (N = 96), and one population-based reference
group (N = 1956).
Method. Obtained were the European Organization for Research and Treatment of Cancer Core Quality of Life Ques-
tionnaire (EORTC QLQ), the Voice Handicap Index (VHI), and the Eysenck Personality Inventory (EPI) neuroticism
scores.
Results. By analysis of variance, we have determined significant dependence of groups analyzing the sum global QoL/
health index (F = 9.47; P < 0.001), the functional HRQoL sum score (F5,2373 = 7.14, P < 0.001), and the symptom sum
HRQoL scores (F7,2381 = 8.13; P < 0.001). In particular, patients with recurrent palsy and laryngeal cancer had lowered
HRQoL. At the index levels, in particular dyspnea scores, were scored depending on larynx disease group (F7,2288 = 24.4;
P < 0.001). The VHI score correlated with the EORTC H&N35 “speech” index with a common variance of 52%. VHI
scores correlated with level of neuroticism with 8% common variance (P < 0.001) and EORTC scores with 22% (P < 0.001).
Conclusion. In particular, among patients with voice-related disease, those with recurrent palsy and laryngeal cancer
had lower HRQoL. Furthermore, the HRQoL and VHI scores were inversely tied to neuroticism.
Key Words: EORTC QLQ–Voice Handicap Index–Norwegian–voice disorders–quality of life.
INTRODUCTION
Patients with voice-related disorders are often examined and treated
by a team including an ear, nose, and throat specialist and a speech
therapist. This requires registering clinical and patient-reported in-
formation as reliable and valid as possible. The European
Laryngological Society has proposed a basis protocol for assess-
ment of voice-related diseases,1 which includes assessment by
patient-reported outcome measures.Aims of this protocol include
allowing comparison of treatments of voice-related diseases across
cultures, as well as assessing impact of voice disorders in the health-
related quality of life (HRQoL). This may include both general
and symptom-specific HRQoLitems.2 The understanding of HRQoL
among patients with larynx disease is, however, limited and should
therefore be of high interest to investigate.
The European Organization for Research and Treatment of
Cancer (EORTC) has developed a line of HRQoL question-
naires aimed at cancer patients.3 These HRQoL questionnaires
consist of one questionnaire developed as a general HRQoL
questionnaire,3 as well as many site-specific questionnaires.4 The
EORTC Core Quality of Life Questionnaire (QLQ)-C30 general
questionnaire consists of nine multi-item scales, five function-
al scales, three symptom scales, one global health scale, and one
global HRQoL scale. Several single-item symptom measures are
also included. Although developed with an aim at evaluating the
HRQoL of cancer patients, this questionnaire has also been sug-
gested to be used to assess HRQoL in general.5,6 Norwegian
population norms are also available.7,8 As patients with larynx
disease include cancer patients, this questionnaire may be useful
among mixed patients with larynx disease. An aim of this in-
vestigation is thus to study the EORTC QoL questionnaire yield
among patients with larynx disease.
Several patient-reported outcome measures aimed at measur-
ing the specific impact of voice-related diseases on activities of
daily life have been developed.9 The Voice Handicap Index (VHI)
constitutes one such example and includes questions measur-
ing various perceived consequences of voice disease. The Agency
for Healthcare Research and Quality reported in 2002 that the
VHI met stringent criteria for reliability, validity, and availabil-
ity of normative data.10 The VHI has been translated into many
different languages. Verdonck-de Leeuw et al11 have validated
the VHI by assessing equivalence of European translations of
the questionnaire to the following languages: German, French,
Dutch, Italian, Portuguese, Belgian, and Swedish.11 A Norwe-
gian translation has also recently been published.12 Several
investigators have furthermore used VHI scores to study effects
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of larynx disease treatment.13–15 The VHI may be viewed as a
voice-specific HRQoL instrument.16 One present aim was to study
the relation between the VHI score and the various EORTC QLQ
scores.
Studies investigating HRQoL in relation to psychosocial con-
ditions among patients are an emerging interest in medicine, and
such research show that especially personality is associated to
HRQoL scores more closely than disease-derived factors.17–19 To
study this further among patients with larynx disease has also
been an aim of the present investigation.
The aims of this study were to investigate HRQoL among pa-




This study consists of four cohorts:
I: Cohort of Haukeland University Hospital (HUH) pa-
tients with voice disease
The participants (N = 229) consisted of 138 men (median age
61, range 24–86) and 91 women (median age 51, range 18–79)
and were included consecutively following appointments at the
laryngology clinic at HUH. The clinic receives patients re-
ferred both from family physicians and from surrounding private
practice ear, nose, and throat specialists. The patients received
the questionnaires in an envelope at the consultation and re-
turned the questionnaires by mail after filling out answers at home.
The return rate of the questionnaires was 81%. The character-
istics of these patients are given in Table 1.
II: General Norwegian reference
A randomly selected sample of 3000 people, reflecting the age
and gender distribution of the adult Norwegian population, was
obtained by a random draw from the adult Norwegian popula-
tion. Of the 3000 invited, 1956 returned the questionnaire and
were available for analyses. The EORTC QLQ-C30 (version 2.0)
and a questionnaire about demographic data and health were
mailed. Detailed information about these reference HRQoL data
has been published previously.7,8
III: Cohort of patients from HUH formerly treated for head
and neck squamous cell carcinoma (HNSCC)
This group included 96 successfully treated patients with
HNSCC from western Norway aged less than 80 years who were
primarily treated at HUH. HRQoL data were collected a median
of 4 years after the primary diagnosis of HNSCC. The patients
with HNSCC responded to the questionnaires by structured in-
terviews. The patient, tumor, and therapy characteristics have
been published previously.3
IV: Cohort of National Norwegian Laryngectomies (NLS)
All patients with laryngectomy in Norway become members
of the NLS, a subsidiary of the Norwegian Cancer Society. Copies
of EORTC QLQ-C30 (version 3.0) were mailed to all regis-
tered members of the NLS below 80 years of age. A second
invitation was mailed if the patients did not respond to the first.
In total, 104 patients answered the questionnaires, and the spe-
cific data have been published previously.20 The vast majority
of these patients were laryngectomized owing to cancer of the
larynx.
Cohort I diagnostic workup
The patients were subjected to standard medical and voice ther-
apist examination according to the standard procedure suggested
by the European Laryngological Society.1 The diagnostic
groups were set according to previously published flowcharts21
(Table 1).
TABLE 1.
Number of Voice Patients Included, Age, Sex, Voice Use, Reported Degree of Voice Problems, Smoking, and Group
Allocation, by Diagnosis (n = 229)
Number Age Voice Use Voice Problem Smoking









Cancer 80 7 67 37–85 45 18–91 59 15 70 Cancer
Recurrent palsy 32 16 59 34–79 64 27–91 13 19 19 Recurrent palsy
Dysfunctional 23 15 55 29–77 82 18–100 12 11 6 Dysfunctional
Reinke edema 16 12 54 42–69 73 36–100 9 7 15 Degen./Inflam.
Laryngitis 16 9 73 40–86 55 27–91 10 6 9 Degen./Inflam.
Polyp 17 7 46 25–62 82 45–91 6 11 11 Degen./Inflam.
Cyst 12 6 50 20–71 68 9–91 8 3 4 Degen./Inflam.
Papilloma 8 3 39 21–54 77 64–82 4 4 2 Degen./Inflam.
Dysplasia 6 2 63 54–72 73 36–100 5 1 5 Degen./Inflam.
Other 12 8 58 21–81 45 36–100 6 6 8 Others
Nodules 6 5 29 18–43 100 55–100 1 4 1 Dysfunctional
Aphonia 1 0 56 56 57 57 0 1 0 Others
Total 229 90 59 21–86 64 9–100 133 88 150
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The VHI
Members of cohort I answered the VHI. The VHI includes 30
statements (items).22 The patients answer on a 5-point Likert-
type scale (from 0 = never to 4 = always). The total VHI sum
score ranges from 0 to 120 points. The highest value repre-
sents maximum level of self-experienced voice handicap. The
questionnaire has been translated into Norwegian.12
EORTC QLQ HRQoL measure
The general HRQoL of the patients was assessed using the
EORTC QLQ-C30 questionnaire.3 The QLQ-C30 contains a
global health scale, five functional scales (physical, role, cog-
nitive, emotional, and social), three symptom scales (fatigue, pain
and nausea/vomiting), and six single items (dyspnea, insom-
nia, anorexia, constipation, diarrhea, and financial difficulties).
To the members of cohort I, some indexes from the EORTC QLQ-
H&N35 questionnaire were also included (speech, teeth problems,
opening mouth, dry mouth, sticky saliva, coughing, and feeling
ill).23 The answers were given according to a 4-point Likert format,
with the exception of questions about general health and quality
of life, which are given according to a 7-point Likert format.
All responses were scored in accordance with the EORTC Scoring
Manual. The C30 functional scales and the global scale were
transformed so that 100% indicates best function and 0% indi-
cates least function on the individual QoL index, whereas the
C30 symptom and H&N35 scales were transformed so that 0%
indicates the lowest and 100% indicates the most serious symp-
toms. The Cronbach alpha values of the sum scores of functional
indexes (α = 0.85) and symptoms indexes (α = 0.82) were
satisfactory.
Additional questionnaires used
Cohort I answered in addition questions about background in-
formation regarding occupation, a 4-point Likert scale stating
how seriously the voice disease was experienced, and a 7-point
Likert scale about level of voice use (1 = quiet listener; 7 = ex-
tremely talkative) at home and at work.
Statistics
We used a commercially available statistical program package
(SPSS Statistics 22.0, IBM, Armonk, NY, USA) for statistical
analysis. Statistical significance was considered if P < 0.05. All
P values reported represent two-sided tests. Cronbach alpha,
Pearson correlation, partial correlation, and multivariate anal-
ysis of variance (MANOVA) analyses followed by post hoc
Bonferroni method were calculated as indicated.
RESULTS
HRQoL related to diagnoses (all cohorts)
We have determined significant dependence of disease group ana-
lyzing the sum global QoL/health index (F7,2362 = 9.47; P < 0.001)
(Figure 1). Post hoc analyses showed that the reference popu-
lation scored higher than the patients with recurrent palsy and
(P < 0.001) and the patients with degenerative or inflammatory
disease (P = 0.002). Furthermore, patients with recurrent palsy
scored lower than the patients formerly treated for HNSCC and
the laryngectomized patients. Finally, patients with degenerative/
inflammatory disease scored lower than the patients formerly
treated for HNSCC.
When analyzed using functional HRQoL sum score as de-
pending factor, a significant effect of group allocation
(F7,2373 = 7.14, P < 0.001) was determined (Figure 1). Post hoc
analyses showed that the laryngectomized patients (P < 0.001)
and the patients with recurrent palsy (P < 0.05) scored lower than
the reference population.
The emotional index was scored depending on group
(F7,2210 = 4.57; P < 0.001) (Figure 2). The only significant dif-
ference was that the mean of the reference population was higher
than the mean of the laryngectomized group. The cognitive index
was also scored depending on group (F7,2210 = 2.74; P < 0.01),
but no particular group difference was observed following post
hoc analysis.
The physical index was also scored depending on group al-
location (F7,2210 = 12.19; P < 0.001) (Figure 2). Post hoc analyses
showed that the reference population scores were higher than
those of the laryngectomized patients (P < 0.001), patients with
HNSCC, and the patients with laryngeal cancer (P < 0.05). In
addition, patients with degenerative/inflammatory disease scored
higher than the laryngectomized group. The social index was
also scored depending on group allocation (F7,2210 = 13.6;
P < 0.001) (Figure 1). Post hoc analyses showed that the ref-
erence population scored higher than all the specific patient groups
(P < 0.05–0.001), except the general HNSCC group. Further-
more, the recurrent palsy group scored lower than the general
HNSCC group (P < 0.05). The role index was also scored de-
pending on group (F7,2210 = 4.69; P < 0.001). Post hoc analyses
showed that the scores of patients with recurrent palsy were lower
than the scores of the reference population (P < 0.001).
ANOVA analyses with the symptom sum HRQoL scores
showed a significant effect depending on group allocation
(F7,2381 = 8.13; P < 0.001) (Figure 1). Post hoc analyses showed
that scores of the reference population were significantly lower
than that of the laryngectomized group (P < 0.001) and recur-
rent palsy group (P < 0.05). In addition, the laryngectomized
patients scored lower than the patients with general HNSCC and
patients with degenerative/inflammatory larynx disease (both
P < 0.05).
At the EORTC C30 index levels, in particular dyspnea, scores
were scored depending on disease group (F7,2288 = 24.4; P < 0.001)
(Figure 3). All patient groups, except those formerly treated for
HNSCC and the dysfunctional group, scored with more symp-
toms than the reference population (P < 0.001). In addition, the
laryngectomized patients (P < 0.001) and those with recurrent
palsy (P < 0.05) scored with more symptoms than the group of
patients formerly treated for HNSCC (P < 0.001). Level of fi-
nancial strain was also scored depending on disease group
(F7,2288 = 7.6; P < 0.001). In particular, the laryngectomized pa-
tients (P < 0.001) and those with recurrent nerve palsy (P < 0.05)
reported more financial strain than the reference population.
MANOVA analyses when including the “dyspnea” indexed
as covariate removed the dependence of “diagnostic group” from
the functional and symptom sum score results, but not from the
global QoL/health sum score results (results not shown).
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HRQoL scores related to VHI scores (cohort I)
When analyzing the results from cohort I, we found that the cor-
relation between the different HRQoL sum scores among the same
patients was, as expected, substantial with a common variance
ranging from 33% to 72% (P < 0.001) (Table 2). The VHI scores
also correlated with the HRQoL sum scores with 12% to 20%
common variance (P < 0.001) (Table 2). From cohort I, the dif-
ferent EORTC H&N35 indexes obtained also correlated with each
other (Table 3). Furthermore, the VHI scores correlated closely
with the “speech” index with a common variance of 52%
(Figure 4). The VHI scores in addition correlated with the other
obtained EORTC H&N35 indexes with a common variance
varying between 2.5% and 14%, with the strongest correlation
toward “feeling ill” (Table 3).
VHI scores related to age, gender, smoking history,
and level of voice use (cohort I)
We observed a negative correlation between the VHI scores and
the age of the patient with 3% (P < 0.01) common variance. About
the same level of common variance was observed between VHI
and gender, with women scoring lowest. No significant corre-
lation was obtained between pack-years smoking and VHI scores
when adjusted by age and gender of the patients. No system-
atic reported dependence on level of voice (professional/
leisure) use and VHI scores (Table 4) was observed.
Importance of EPI score levels on HRQoL and VHI
score levels (cohort I)
The neuroticism scores correlated with HRQoL levels, with values
ranging from 22% to 23% (P < 0.001) (Table 2) in patients of
cohort I. The VHI scores also correlated with reported level of
neuroticism with a common variance of 8% (P < 0.001). Partial
correlation analysis with neuroticism as covariate and HRQoL
and VHI scores as variables furthermore showed a common vari-
ance ranging from 7% to 14%, indicating that a substantial part
of the common variance of HRQoL sum scores and VHI was
secondary to level of neuroticism. We also divided the patients
in cohort I in two groups based on low or high level of neuroti-
cism. A MANOVA analysis with diagnostic group as one
dimension and level of neuroticism as a second dimension showed
results highly dependent on both VHI score (F4,228 = 6.3;
P < 0.001) and level of neuroticism (F1,228 = 12.6; P < 0.001), but
there was no interaction between these dimensions (F4,228 = 0.65;
P = 0.625) (Figure 5).
DISCUSSION
We have studied the associations between HRQoL and specific
diagnoses in a cohort of patients with voice-related disease com-
pared with a reference cohort, to patients successfully treated
for general HNSCC and to previously laryngectomized pa-
tients. The results showed that in particular, patients with recurrent
palsy and laryngeal cancer had lowered general HRQoL. The
HRQoL variables were furthermore inversely tied to neuroticism.
The results show that the HRQoL scores were scored de-
pending on specific laryngeal disease. In particular, three of the
included groups scored with lower HRQoL than the reference
population, that is, the laryngectomized patients, the patients with
laryngeal cancer, and the patients with recurrent nerve palsy. It
is to be expected that cancer patients score with lower HRQoL
than a general cohort. Laryngectomized patients must in par-
ticular be expected to suffer from the sequels of the cancer
disease.20 Despite this, the HRQoL scores of the larynx cancer
disease groups are indicated to be relatively numerically similar
to that of the other disease groups studied.
We have chosen to group the specific larynx diseases based
on a previous study of which diseases scored as clusters as mea-
sured by the VHI scores.21 These groups were furthermore in
general agreement with the grouping as suggested by Verdonck-
de Leeuw et al11 and Nawka et al24 reporting from a multicenter
study based on VHI scores from patients with benign larynx dis-
eases from many different sites across Europe. As to the HRQoL
scores, it is possible that if other lines to distinguish the pa-
tients are employed, there would have been sharper lines between
the patient groups.
The patients with recurrent nerve palsy in particular scored
with low HRQoL. Many of these patients have serious diseases,25
and judging on this background, lowered HRQoL scores are not
surprising. The symptoms characterizing this disease also inflict
reduced functional capacity.25 In line with this, Rosen et al26 have,
for example, found that among patients with larynx disease, worst
FIGURE 1. Patients with larynx disease versus patients with head and neck squamous cell carcinoma (HNSCC) versus general population (sum
scores):
European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ)” (A) general quality of life (QoL)/
health, (B) C30 sum functional, (C) C30 sum symptom.
Answers were given according to a 4-point Likert format, except for questions about general health and quality of life, which were given accord-
ing to a 7-point Likert format. The functional indexes (from population) of the C30 version 2.0 were scored according to a 2-point Likert format.
The C30 functional scales and the global scale were transformed so that 100% indicates best function and 0% indicates least function of the in-
dividual QoL index, whereas the C30 symptom scales were transformed so that 0% indicates the least and 100% indicates the most symptoms. (B)
Sum scores of physical, role, cognitive, emotional, and social indexes. (C) Sum scores of fatigue, pain and nausea/vomiting, dyspnea, insomnia,
anorexia, constipation, diarrhea, and financial difficulties indexes.
Statistics: Global QoL/health depending on group allocation: F7,2362 = 9.47, P < 0.001. Post hoc analyses: population > recurrence palsy and degenerative/
inflammatory. Recurrence palsy < formerly treated for HNSCC and laryngectomized. Degen./inflammatory < formerly treated for HNSCC. Functional
HRQoL sum score depending on group allocation: F7,2327 = 7.14, P < 0.001. Post hoc analyses: population > laryngectomized, recurrence palsy.
Symptom sum HRQoL sum scores depending on group allocation: F7,2381 = 8,13, P < 0.001. Post hoc analyses: population < laryngectomized and
recurrent palsy. Laryngectomized > formerly treated for HNSCC and degen./inflammatory.
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VHI scores were obtained from those with unilateral vocal fold
paralysis. Helidoni et al27 and Lam et al28 have furthermore de-
termined in their studies of patients with larynx disease that the
neurogenic group had the worst VHI scores. The present results,
together with the abovementioned studies, support that pa-
tients with recurrent palsy as a group suffer broadly reduced
HRQoL.
The HRQoL scores were not generally dependent on gender
or age of the included subject. This is also supported by find-
ings from other studies.27,29 We have, however, determined a
negative correlation between age of the patients and VHI scores.
This is interesting and needs further investigation. Patients were
asked to report whether they are smoking. We have not deter-
mined any specific effect of smoking directly on the HRQoL
scores.
Patients with degenerative or inflammatory benign disease
scored lower than the reference population in the global QoL/
health score. Thus, having these limited larynx diseases had an
FIGURE 3. Patients with larynx disease versus patients with head and neck squamous cell carcinoma (HNSCC) versus general population (symptom
indexes):
EORTC QLQ C30 indexes were used. Scores are calculated as given in Figure 1 legend.
(A) C30 dyspnea, (B) C30 financial strain.
Statistics: Dyspnea index scores depending on group: F7,2288 = 24.4, P < 0.001. Post hoc analyses: Population < all other groups except group for-
merly treated for HNSCC and degen./inflammatory group. Laryngectomized and recurrent palsy > patients formerly treated for HNSCC.
Financial strain index dependent on group: F7,2288 = 7.6, P < 0.001. Post hoc analyses: population < laryngectomized and recurrence palsy.
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impact on the general well-being of the patients. Furthermore,
the symptom index “dyspnea” from the general EORTC QLQ
was in particular scored depending on larynx disease. Second-
ary analyses even suggested that alleviating dyspnea would
remove most of the impact of larynx disease on HRQoL. Larynx
airway obstruction as a key feature of larynx disease should
thus be further studied. This also supports the need for treat-
ment of patients with larynx disease. The often relatively simple
TABLE 2.
Correlation Matrix Between Sum Scores Derived From the General (C30) EORTC QLQ, VHI, and EPI Scores Among













General health /QoL −.42***
Functional QoL sum −.45*** .63***
Symptom QoL sum .35*** −.58*** −.85***
EPI neuroticism −.28*** .47*** .47*** −.48***
EPI lie .03 −.10 −.02 .04 −.23***
EPI extraversion .10 −.21*** −.19** .16* −.18** −.08
* P < 0.05.
** P < 0.01.
*** P < 0.001.
TABLE 3.
Pearson Correlation Matrix Including VHI Scores and Some EORTC H&N35 QLQ Indexes Among Patients With Voice Disease
(Cohort I)
VHI Speech Teeth Problems Open Mouth Dry Mouth Sticky Saliva Coughing
Speech .72***
Teeth problems .09 .16*
Open mouth .19** .07 .22***
Dry mouth .16* .215*** .38*** .291***
Sticky saliva .18** .29*** .32*** .26*** .56***
Coughing .26*** .37*** .17** .07 .31*** .47***
Feeling ill .37*** .40*** .14* .17* .26*** .30*** .45***
* P < 0.05.
** P < 0.01.
*** P < 0.001.
FIGURE 4. Scatter plot from VHI sum scores versus EORTC H&N35 “speech” index.
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treatment of such diseases may thus give excellent global HRQoL
yield.
We have determined that the level of financial strain was scored
depending on larynx disease. In particular, the laryngecto-
mized patients and the patients with recurrent nerve palsy reported
higher scores on such strain. The fact that such questions give
useful answers should encourage including these matters in the
follow-up of patients with laryngeal disease.
The VHI scores correlated closely with the EORTC QLQ index
“speech.” This may be viewed as an additional strong argu-
ment that the VHI scores resemble a symptom-specific HRQoL
variable. These results are to some extent surprising as the VHI
asks to a large extent about voice disability in a social context.
One could possibly conclude that the framing of a question is
less important than the factual information the questions are asking
about. This should be more closely studied.
This study has weak points. First, it is a cross-sectional study.
Furthermore, some of the information about the social condi-
tions of the included patients should be obtained as degree of
social support is associated to HRQoL.30 It is also missing in-
formation about present comorbidities of the included patients,
which is important as such conditions are known to influence
the HRQoL scores.31
It should be noted that some of the groups show large HRQoL
standard deviations, indicating that matters other than the specif-
ic diagnosis contribute to the HRQoL scores. Level of neuroticism
is known to have a major impact on HRQoLscores in various patient
groups.32 Thus, it is of relevance to determine this impact when
acquiring HRQoL of patients with larynx disease. We have shown
that level of neuroticism was correlated to the HRQoL scores and
to VHI scores with a substantial common variance. In addition,
some of the common variance between the HRQoL and the VHI
scores were secondary to level of neuroticism. The impact of neu-
roticism on the VHI scores in addition strengthens the view that
the VHI score may be classified as a HRQoL score.
Among the patients with larynx disease, the EORTC-H&N35
“speech” index in particular was scored with a close association
to the VHI score. This suggests that the VHI questionnaire may
TABLE 4.
Correlation Scores (Pearson) Between Reported EORTC C30 QLQ/VHI Scores and Age, Gender, as well as Reported Speech
Difficulty, Amount of Voice Use, and Pack-years of Smoking Among Patients With Voice Disease (Cohort I)
VHI General Health/QoL Functional QoL Sum Symptom QoL Sum
Age −.17** .04 .09 −.04
Gender −.17* .09 .14* −.13
Speech difficulty .67*** −.39*** −.34*** .27***
Professional use of voice .03 .12 .10 −.15*
Leisure use of voice .03 .04 .05 −.04
Smoking (pack-years) −.13* −.04 −.03 .04
* P < 0.05.
** P < 0.01.
*** P < 0.001.
FIGURE 5. VHI scores depending on low versus high neuroticism scores versus larynx diseases.
Blue circles = low neuroticism; red diamonds = high neuroticism.
Statistics: MANOVA analysis with group as one dimension and level of neuroticism as a second dimension showed results highly dependent on
both VHI score (F4,228 = 6.3; P < 0.001) and level of neuroticism (F1,228 = 12.6; P < 0.001), but there was no interaction between these dimensions
(F4,228 = 0.65; P = 0.625). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
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be used generally in conjunction with the EORTC QLQ when
the EORTC-H&N35 speech index is scored with a high value in
order to validate this score.
The present investigation underlines the importance of voice
in larynx disease as associated also to general HRQoL, and sug-
gests that voice patency contributes substantially to the generation
of good HRQoL, at least in patients with larynx disease, which
in turn further strengthens the view that voice-improving treat-
ments generate better HRQoL among patients with larynx disease.
This study shows that HRQoL scores may yield information
when included in clinical routine laryngological consultations.
Some of the differences between the groups reached 10 HRQoL
points, which is consistent with being of clinical relevance.33 A
general HRQoL questionnaire will provide additional informa-
tion about the patient and is therefore recommended to be included
as part of a complete investigation of patients with voice disease.
CONCLUSIONS
We have shown among patients with larynx disease that, in par-
ticular, cancer patients and patients with recurrent palsy had
lowered general HRQoL. The general EORTC QLQ and the VHI,
as voice-specific HRQoL measures, may be recommended in the
standard protocol for assessment of patients with voice disease.1
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Acoustic Voice Analysis and Maximum Phonation Time in
Relation to Voice Handicap Index Score and Larynx Disease
**,†,‡Tom Karlsen, *Lorentz Sandvik, *,†John-Helge Heimdal, and *,†Hans Jørgen Aarstad, *yzBergen, Norway
Summary: Objectives. Patients with voice-related disorders are ideally treated by a multidisciplinary team.
Acoustic voice analysis and patient-reported outcome measures are recommended parts of the clinical assess-
ment. The present paper aims at further documenting the importance of acoustic voice analyses, maximum pho-
nation time (MPT) and Voice Handicap Index (VHI) into clinical investigations.
Study design. The participants (N = 80 larynx cancer, N = 32 recurrent palsy, N = 23 dysfunctional,
N = 75 degenerative/inflammation (N = 19 various excluded)) were included consecutively at the outpatient lar-
yngology clinic at Haukeland University Hospital. In addition, a control group of 98 healthy subjects were
included.
Method. Voice samples, MPT, and the VHI scores in addition to standard clinical information were obtained.
Acoustic analyses were performed from these samples determining level of jitter, shimmer and Noise-to-Har-
monic ratio (NHR) as well as analyzing frequency of a prolonged vowel.
Results. Jitter, shimmer, and NHR scores correlated strongly (r  0.8; P < 0.001) to each other. By Analysis of
Variance analyses, we have determined significant dependence on diagnostic group analyzing all the obtained
acoustic scores (all P < 0.001). All patient groups but the dysfunctional group scored to some extent worse than
the control group (mostly at P < 0.001). In addition, jitter scores from dysfunction group were lower than
recurrent palsy group (P < 0.05) and shimmer scores were lower among dysfunctional than the cancer group
(P < 0.05). Regarding NHR the cancer patients scored higher than the degenerative/inflammatory group
(P < 0.05). The cancer group scored with longer MPT than the degenerative/inflammatory (P < 0.001) and
recurrent palsy groups (P < 0.05).
Conclusion. Among larynx disease patients acoustic and MPT analyses segregated with all determined analyses
between patients and control conditions except the dysfunctional group, but also to some extent between various
patient groups. VHI scores correlated to jitter, shimmer and NHR scores among cancer and degenerative/inflam-
matory disease patients. Acoustic analyses potentially add information useful to laryngological patient studies.
Key Words: Acoustic voice analysisMaximum phonation timeVoice handicap indexNorwegianVoice
disorders.
INTRODUCTION
The European Laryngological Society (ELS) has proposed
a basis protocol for assessment of voice-related diseases1
which recommends including assessment by acoustic analy-
sis, aerodynamics, and patient-reported outcome measures
(PROM). This ELS protocol encourages comparing
patients with voice-related diseases by measurement of the
voice physical function in order to assess the importance of
such measurements when assessing patients with voice-
related disease.1,2 Such data should aid to study voice char-
acteristics stringently and support to discriminate between
various larynx diseases, as well to assess treatment effi-
ciency. There is still a need to study the benefit of employing
acoustic parameters in relation to diagnosis and treatment
of voice-related diseases.3,4 A goal of all, laryngological
inclusive, patient treatment is to improve PROM scores to
normal level values.5 In order to do so it is of interest to
study to what extent acoustic physical analyses can point to
important matters regarding associations to the PROM
scores.
One theory behind acoustic analyzes of voice has been
that the changes in vocal fold mass, or tension leads to
increased and measureable irregularity or noise in the sound
of the voice sample.6,7 Noise could be defined as random
aperiodic energy in the voice,8 and may have two main
causes. It could be a sources of noise near, or at the vocal
folds, (ie, the airstream between the vocal folds), or a signifi-
cant aperiodicity in the glottis wave of the vocal folds.8 The
ELS protocol recommends fundamental frequency (F0), rel-
ative jitter, and shimmer as pertinent parameters1 of acous-
tic analysis. The ELS also suggests Noise-to-Harmonic
ratio (NHR) as a robust acoustic measure,1 but points out a
lack of standardizing among different analyzing methods
regarding this parameter.1 These four parameters are the
commonly used parameters within acoustic analysis of voice
samples6,9,10; and thus employed in this study.
Voice frequencies deviation (jitter) or voice amplitude
deviation (shimmer) quantifies the unintentional irregularity
of the sound waves.9 Jitter, also known as frequency pertur-
bation, measures the variation from the cycle-to-cycle
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within the fundamental frequency of a voice signal.7,8 Shim-
mer, known as amplitude perturbation, measures the varia-
tion from the cycle to cycle within the amplitude.9 Studies
which have combined several different acoustic parameters
and visual examination of the larynx suggest jitter and shim-
mer to be valuable in the characterization of voice pathol-
ogy.11,12 NHR represents a global measure of noise in the
voice sample.13 Irregularity of the acoustic measures may to
some degree viewed as normal variation, and this variation
may be depended on gender, age, language, and culture.14-
17 This has to be kept in mind during studies of acoustic
parameters in voice pathology.
Fundamental frequency (F0) is a measure of the lowest
detectable frequency of the voice. The frequency of a sound
is defined as number of complete oscillations per second. In
the human voice this corresponds to number of complete
open-close cycle of the vocal folds per second. The ELS pro-
tocol recommends fundamental frequency (F0) and the fun-
damental frequency has been determined by Wuyts et al to
be associated with VHI values8 and thus should be an inter-
esting parameter to include within voice analyses.
Maximum phonation time (MPT) is an aerodynamic
parameter, and according to the ELS protocol, the easiest
and most common used technic to measure aerodynamics
in voices.1 MPT reports the maximum length of a continu-
ous phonation of a vowel in seconds. Inadequate closure of
the vocal folds would give a short MPT due to increased air
leakage through rima glottidis. Studies have found correla-
tion between low MPT and pathology of the larynx.18,19 An
aim of this study has also been to further investigate the pos-
sible associations between MPT, acoustic analysis, and
voice disorders.
Several PROMs aimed at measuring the specific impact
of voice-related diseases on activities of daily life have been
developed.20 The Voice Handicap Index (VHI) constitutes
one such example and includes questions measuring various
perceived consequences of voice disease. The Agency for
Health Care Research and Quality reported in 2002 that the
VHI met stringent criteria for reliability, validity, and avail-
ability of normative data.21 Verdonck-de Leeuw et al.22
have validated the VHI by assessing equivalence of Euro-
pean translations of the questionnaire to the following lan-
guages: German, French, Dutch, Italian Portuguese,
Belgian, and Swedish.22 A Norwegian translation has also
been published.23 Several investigators have utilized VHI
scores in order to study effects of larynx disease treat-
ment.24-26 Studies have suggested that VHI score levels cor-
relate with acoustic measures.27 It has been an aim of the
study to investigate the relation between acoustic measures,
MPT, and VHI.
It should furthermore be of interest to study the acoustic
variable scores in healthy control persons, and this has been
one major aim of the present investigation to gather a con-
trol group and to compare such scores with the various
patient groups. In particular, it seems to be of interest to
study to what extent functional disease acoustic measures
differ from control conditions.
Acoustic parameters derived from voice samples should
have the ability to discriminate between controls and differ-
ent laryngological diseases.28 Our primary aim has been to
study in more detail the ability of acoustic parameters to dif-
ferentiate between various laryngological diseases con-
trasted to healthy controls. Our secondary aim has been to
study fundamental frequency, jitter, shimmer, NHR, and
MPT value correlations to VHI both generally including a
healthy control group, and at an individual disease level.
MATERIAL AND METHODS
Participants
Cohort of Haukeland University Hospital (HUH) voice-
diseased patients
These participants (N = 229) consisted of 138 men (median
age 61, range 24-86) and 91 women (median age 51, range
18-79) and were included consecutively following appoint-
ments at the laryngology clinic at HUH. The clinic receives
both patients referred from family physicians and from sur-
rounding private practice ENT specialists. The patients
received the questionnaires in an envelope at the consulta-
tion and return the questionnaires by mail after filling out
answers at home. The return-rate of the questionnaires was
81%. The patients were subjected to standard medical and
voice therapist examination according to the standard pro-
cedure suggested by ELS.1 The diagnostic groups were set
according to a previously published flow chart.28 In short,
the recurrent palsy patients all had the vocal cords in classi-
cal para-median position. Nineteen had palsy on the left
and 13 on the right side. The cancer patients had all previ-
ously been treated because of laryngeal cancer. The degen-
erative/inflammatory group consisted of patients with
Reinke edema (16), laryngitis (16), polyp (17), cyst (12),
papilloma (8), and nodules (6). Patients with dysfunctional
disease were patients with symptoms caused by misuse of
the voice box, but without any physical pathology visible by
laryngoscopy. The characteristics of the presently included
patients are given in Table 1. The patients have also formed
the basis for two previous publications. More details about
the patients may be gathered form these publications.28,29
Control group
The control group consisted of 106 healthy volunteers
recruited by information posters and letters distributed to
the hospital, university employees, and students. The inclu-
sion criteria were that they signed an informed consent,
were above 18 years of age, underwent video-laryngo-stro-
boscopy, recorded a successful voice sample, and answered
the VHI questionnaire. Furthermore, cognitive functions
and language skill needed to answer the VHI questionnaire
intelligible in Norwegian were required. If the controls were
diagnosed with larynx pathology at the video-laryngo-stro-
boscopy, they were excluded from the study. Eight partici-
pants were excluded either due to findings of larynx
pathology, did not complete the examination or had missing
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VHI questionnaire. This constitutes 8.5% dropout, and a
total of 98 participants were included in the study, median
age 34 years and range 19-74 years. Thirty-tree males,
median age 32 year, range 19-63 years, and 65 women,
median age 35 year, range 22-74 years were included.
Voice samples
Voice recordings were obtained from both patients and con-
trols at the laryngology clinic at HUH. The voice recordings
were obtained computer based through a standardized pro-
cedure in a small sound proof (insulated) room with the use
of software from Key Elemetrics, Multi Speech model 3700
and Multi-Dimensional Voice Program model 5105. The
Shure SM 81 condenser microphone with mounted pop-fil-
ter was placed 30 cm in front of the subjects at an angle of
35°. The recording box was dedicated to the purpose and
designed to limit surrounding noise. Instructions were thor-
oughly given to ensure that all the recordings were per-
formed according to the standardized procedure with equal
distance from the microphone. The subjects were first pro-
ducing a prolonged vocal /A/, then reading of a standard-
ized text (The north wind and the sun), and lastly repeating
the prolonged vocal /A/. The technically judged best perfor-
mance of the prolonged vocal /A/ was chosen, from which
both the acoustic analysis and MPT were obtained. This
was usually the lastly obtained vowel. In the acoustic analy-
sis the midsection of the prolonged vocal was used. The soft-
ware Multi-Dimensional Voice Program (MDVP) from
Kay Elemetrics was also used to analyze the voice samples.
The parameters F0, Jitter (jitt %), Shimmer (shim %), and
NHR and maximum phonation time (MPT) were reported.
The Voice Handicap Index
Both patients and controls answered the Norwegian VHI.23
VHI includes 30 statements (items).30 The answers are given
according to a five point Likert scale (from 0 = never to
4 = always). The total VHI sum score ranges from 0 to 120
points. The highest value represents maximum level of per-
ceived voice handicap.
Additional questionnaires utilized
The patients answered in addition questions about back-
ground information regarding occupation, a visual ana-
logue scale (VAS) stating how seriously the voice disease
was perceived as well as a 5 or 6 point Likert scale about
level of voice use (1 = quiet listener . 6 = extremely talkative)
both at home and at work.
Statistics
We used a commercially available statistical program pack-
age (IBM Corp. Released 2012. IBM SPSS Statistics for
Windows, Version 24.0 Armonk, NY: IBM Corp). Statisti-
cal significance was considered if P < 0.05. All P values
reported represent two-sided tests. Pearson correlation, lin-
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analyses followed by post hoc tests (Bonferroni method)
were calculated as indicated.
RESULTS
Acoustic score and MPT relations to age and gender
of the included subjects
The characteristics of the presently included patient data are
given in Table 1. All the determined acoustic scores were on
group level dependent on gender of the included subjects
(Table 2). In particular, F0 (r = 0.57; P < 0.001) showed
strong dependence. Likewise, all acoustic scores but the
MPT were scored dependent on age of the subject. The
highest correlation was shown to jitter/shimmer (both r 
0.31; P < 0.001) (Table 2).
Acoustic scores and MPT intercorrelation
All the determined acoustic scores inter-correlated signifi-
cantly. The highest values were determined between level of
shimmer and jitter (r = 0.81; P < 0.001). The NHR also cor-
related closely to the shimmer/jitter level (r = 0.81/0.75;
P < 0.001) (Table 2).
Acoustic scores and MPT related to diagnoses
We have determined a dependence of disease group when
analyzing the jitter values dependent on diagnosis by
ANOVA analysis (F4,297 = 13.3; P < 0.001) (Fig. 1). When
subjected to Bonferroni post hoc analyses, the controls
scores were lower than the cancer (P < 0.001), the recurrent
palsy (P < 0.001), and the degenerative/inflammatory
(P < 0.01) groups. In addition, the dysfunctional group
scored lower than recurrent palsy group (P < 0.05). The
shimmer analysis also showed a dependence of group by
ANOVA analysis (F4,297 = 13.1; P < 0.001) (Figure 1).
When subjected to Bonferroni post hoc analyses, the con-
trols scored lower than the cancer (P < 0.001), the recurrent
palsy (P < 0.001), and the degenerative/inflammatory
(P < 0.01) groups. In addition, the dysfunctional group
scored lower than the cancer group (P < 0.05) and the can-
cer group scored higher than the degenerative/inflammation
group (P < 0.05). When performing the ANOVA analysis
with gender and age of the patient included as co-variate
the analyses still determined a dependence on jitter and
shimmer scores on group.
NHR was also scored dependent on diagnosis by
ANOVA analysis (F4,297 = 7.0; P < 0.001) (Figure. 1). By
Bonferroni post hoc analyses the controls scored lower than
the cancer (P < 0.001) and the recurrent palsy (P < 0.05)
patients. Cancer patients in addition scored higher than the
degenerative and inflammatory patients (P < 0.05).
MPT was measured and scored dependent on group by
ANOVA analysis (F4,297 = 6.4; P < 0.001) (Figure 1).
When applying Bonferroni post hoc analyses to diagnosis,
the controls scored with longer duration than the degener-
ative-inflammatory group (P < 0.01). In addition, the
cancer group scored with longer duration than the recur-
rent palsy (P = 0.05) and the degenerative/inflammatory
group (P < 0.001). When performing the ANOVA analy-
sis with gender and age of the patient included as co-vari-
ate the analysis still determined a dependence of MPT on
group.
An ANOVA analysis was performed with F0 as
dependent variable and diagnosis and gender as indepen-
dent variables. This analysis showed a significant depen-
dence on gender (F4,297 = 72.4; P < 0.001), but not on
diagnosis. A significant interaction between gender and
diagnosis (F4,297 = 4.3; P = 0.02) was on the other hand
observed. Therefore, F0 dependent on diagnosis was
analyzed separated by gender. Including males only
ANOVA showed that F0 was scored dependent on diag-
nosis (F4,159 = 3.9; P = 0.005) (Figure 2). When subjected
to Bonferroni post hoc analyses, the male cancer patients
scored lower frequency than the controls (P < 0.01).
TABLE 2.
Correlation Between Maximum Phonation Time (MPT), F0, Jitter, Shimmer, Noise to Harmonic Ratio (NHR), Gender, Age
and Reported Degree of Voice Problems/Voice Use
MPT F0 Jitter Shimmer NHR Age
Maximum phonation time (MPT)
F0 .24***
Jitter .30*** .12*
Shimmer .26*** .12* .81***
NHR .18** .15** .75*** .80***
Age n.s. .13* .32*** .31*** .24***
Gender .29*** .57*** .16*** .15** .11* .30***
Degree of voice problems (patients) .29*** n.s. .23*** n.s. n.s. .17**
Degree of voice use (patients) n.s. n.s. .26*** .27*** .26*** .31***
* Correlation significant at 0.05 level.
** Correlation significant at 0.01 level.
*** Correlation significant at 0.001 level.
n.s.: not significant.
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When including females ANOVA showed that female F0
values were scored dependent on diagnosis (F4,138 = 4.7;
P = 0.001) (Figure 2). Studied by Bonferroni post hoc
analyses the controls scored with higher frequency than
the recurrent palsy (P < 0.05) and the degenerative/
inflammatory female patients (P < 0.01).
Acoustic analyses and MPT scores correlated to VHI
scores
The different acoustic analyses numerical values did not
correlate with the VHI scores among the controls (results
not shown). Among all included patients, the VHI scores
were associated to MPT, jitter, shimmer, and NHR with
common variance ranging from 4% to 10% (all P <
0.001) (Table 3). If the association between VHI and the
acoustic measurements were analyzed by disease group,
significant correlations were shown primarily within the
cancer and degenerative/inflammatory patient groups
(Table 3). Subsequently stepwise regression analyses was
performed including the cancer and inflammatory/degen-
erative “group” patient studying males and females sepa-
rately (Table 4). Age of the patients, level of MPT, F0,
jitter, shimmer, and NHR were included.. Both among
males and females age of the patient and jitter levels
were associated to VHI scores. With males MPT and
with females NHR was uniquely associated to the VHI
scores (Table 4).
FIGURE 1. The jitter, shimmer, noise to harmonic ratio (NHR) and maximum phonation time (MPT) scores (mean §confidence interval)
dependent on group.
Groups: Controls (n = 98), cancer (n = 77), recurrent palsy (n = 31), dysfunctional (n = 22), degenerative/inflammatory (n = 70).
Jitter by ANOVA (F4,297 = 13.3; P < 0.001). Post hoc: controls < cancer (P < 0.001), controls < recurrent palsy (P < 0.001) controls <
degenerative/inflammatory (P < 0.01), dysfunctional < recurrent disease (P < 0.05).
Shimmer by ANOVA: F4,297 = 13.1; P< 0.001) (Fig. 1. Post hoc: controls < cancer (P< 0.001), controls < recurrent palsy (P< 0.001), con-
trols < degenerative/inflammatory (P < 0.01), dysfunctional < cancer group (P < 0.05), cancer > degenerative/inflammation (P < 0.05).
NHR by ANOVA: F4,297 = 7.0; P < 0.001. Post hoc: controls> cancer (P < 0.001), controls> recurrent palsy (P < 0.05), cancer> degener-
ative/inflammatory (P < 0.05).
MPT by ANOVA: F4,297 = 6.4; P < 0.001. Post hoc: controls > degenerative-inflammatory (P < 0.01), cancer > recurrent palsy (P = 0.05),
cancer > degenerative/inflammatory (P < 0.001).
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Acoustic analyses and MPT scores correlated to
reported degree of voice problems and voice use
Among the controls, no significant correlation was deter-
mined between the acoustic measures and the perceived
degree of voice problem. Among the patients, numerical
reported degree of voice problems correlated inversely with
MPT (r =0.29; P < 0.001) and jitter level (r =0.23; P <
0.001) (Table 2), and broken down on diagnostic group sim-
ilar, but weaker associations were shown than as the VHI
analysis results. Furthermore, among patients reported
degree of voice use correlated inversely with level of jitter,
shimmer and NHR (r  0.26; P < 0.001) (Table 2).
DISCUSSION
By employing standard acoustic physical measures as sug-
gested by ELS1,4 we have studied the dependence of the
acoustic voice variables scores on diagnosis as well as corre-
lation to VHI scores of laryngological diseased patients as
well as healthy control persons. All patient groups, except
patients with functional disease, scored different acousti-
cally from the control conditions. Jitter, shimmer, and
NHR scores correlated closely. These parameters were fur-
thermore the acoustic parameters best differentiating
FIGURE 2. The F0 scores (mean §CI) dependent on diagnostic
group separated by gender.
Groups: Controls (n = 98), cancer (n = 77), recurrent palsy (n = 31),
dysfunctional (n = 22), degenerative/inflammatory (n = 70).
Males by ANOVA: F4,159 = 3.9; P= 0.005. Post hoc analyses:
Controls < cancer (P < 0.01). Females by ANOVA: F4,138 = 4.7;
P = 0.001. Post hoc analyses: Controls > recurrent palsy (P <
0.05), controls > degenerative/inflammatory (P < 0.01).
TABLE 3.
Correlation Between VHI Total Score and Maximum
Phonation Time (MPT), F0, Jitter, Shimmer and Noise to
Harmonic Ratio (NHR) Among All Patients, and Depen-









MPT .29*** .39*** n.s.
F0 n.s. .28* n.s.
Jitter .31*** .35** .41***
Shimmer .23*** .28* .42***
NHR .23*** .31** .51***
* Correlation significant at 0.05 level.
** Correlation significant at 0.01 level.
*** Correlation significant at 0.001 level.
n.s.: not significant.
TABLE 4.
Stepwise Linear Regression Analysis With “Cancer” and “Inflammatory/Degenerative” Group Patient VHI Scores as
Dependent Variable and Jitter, Shimmer, Noise to Harmonic Ratio (NHR), Maximum Phonation Time (MPT), and Pro-








(Constant) 5.06 0.000 (Constant) 3.75 0.001
MPT 0.29 2.72 0.008 Jitter 1.10 6.41 0.000
Age 0.29 3.07 0.003 NHR 0.52 3.02 0.007
Jitter 0.24 2.29 0.025 Age 0.31 2.60 0.018
Adjusted R2 0.23 0.70
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between the laryngological diagnoses. The results further-
more showed around 10% common variance between VHI
scores and the acoustic variable scores among the patients;
mostly among cancer and degenerative and inflammatory
patients.
Several limitations, however, are present in this investiga-
tion. First, the data are gathered at one time point only. Sec-
ond, the study could have included more patients. If so, the
ability to differentiate between specific diagnoses could then
have been bettered. Third, the acquisition of acoustic analy-
ses may vary between acquisition systems, computer soft-
ware,31,32 and the individual voice laboratory standard
methods. The lack of a standardized acoustic analysis
obtained across laboratories represents a limitation of com-
paring such parameters in multicenter work. It may also be
suggested that various results between different acoustic lar-
yngological studies to some extent are caused by lack of
such standardization of the analyses. At last, the control
group comprised healthy mostly young subjects giving an
age difference between the controls and the patients. It is
possible that to include elder patients with nonlaryngologi-
cal diseases as controls would have been a better approach
as control conditions. The dysfunctional disease group has,
however, to a large extent scored similar to the control
group, and thus serves to validate the control group.
Jitter, shimmer, and NHR scores correlated closely. This
is in accordance with the findings of findings of Ziwei and
allied.33 These parameters thus seem to reflect a common
underlying entity. The parameters are, however, obtained
by separate analysis of the data and thus add to the reliabil-
ity of the data. Age of the patients may also be of impor-
tance as to acoustic analyses.34,35 This has also been shown
in the present study regarding jitter, shimmer, and NHR.
Acoustic measurement absolute values were presently gen-
erally scored different among males and females which pre-
viously as also have been shown to be the case.36,37 Variable
age and gender did not remove significant results regarding
jitter, shimmer, and MPT on diagnostic group measured by
ANOVA analyses adjusted by age and gender used as co-
variates. Gender influenced the significant differences con-
cerning the F0, and here separate analyses dependent on
gender were conducted. Larger studies are needed in order
to determine more conclusively the importance of age and
gender as to acoustic analyses dependent on diagnosis.
A large variety of diseases affecting the larynx may influ-
ence the voice. To collapse diagnoses into broader groups
are often needed, but challenging in order to analyze results
like the present.28,29 Cancer patients form one group as the
etiology, symptoms and treatment is similar. The same is
the case regarding symptoms from recurrent nerve palsy
patients. As long as acoustic analyses measures physical
symptoms it is to be expected that dysfunctional disease
patients scores as one group alongside control-like scores.
Benign laryngeal disorders that cause dysphonia by affect-
ing the physical structure of the vocal folds also seem perti-
nent to look upon as a group.38 To some extent this is also
the case with laryngitis making it possible to place such
patients in this group. Placement of specific diseased
patients in collapsed groups may, however, be a matter of
discussion, and so far no general guidelines have been
agreed upon. With more patients included, discrepancies
between more specific diseases could have been better
studied.
The F0 values presently scored in particular differently
between males and females.39 We have furthermore shown
that male cancer patients scored with lower frequency than
the male controls. Regarding females, the controls scored
with higher frequency than the recurrent palsy and the
degenerative or inflammatory diseased female patients. To
what extent these findings are gender-related or general
must be determined by future investigations.
One major symptom of recurrent palsy is shortened pho-
nation time per expiration while phonating with expected
reduced MPT.40 MPT was, however, not presently signifi-
cantly decreased among the recurrent palsy patients com-
pared to the controls. Jitter, shimmer and NHR values have
presently been shown to be higher among recurrent palsy
patients than at control conditions, as is previously sup-
ported regarding jitter values.6 Recurrent palsy patients
thus scored to some extent divergent to what we expected
compared to control conditions regarding MPT. This has to
be further studied.
Former cancer patients also scored systematically differ-
ent than the controls regarding the acoustic analyses deter-
mined. This is as expected.18 The degenerative and
inflammatory group also showed pathological values rela-
tive to the control groups. This is in accordance with results
published by Schindler and allied6. Inflammatory or degen-
erative disease patients also scored with more pathology
than the controls. This is in line with Zhuge and allied19
who determined that vocal polyps cause increased jitter.
Patients with dysfunctional diagnosis did not score differ-
ent regarding acoustic analyses than the controls. The phys-
ical characterization of the voice by the measured
parameters was thus as the controls. Acoustic analyses may
thus contribute to finalizing functional diagnoses.
Presently, we have shown that VHI scores correlate with
acoustic measures with about 10% common variance
among all included patients. In particular, this was seen
regarding jitter, shimmer, NHR complex, but mainly
among the cancer and degenerative/inflammatory patients
and primarily tied to jitter. We find it supported that the
perceived voice handicap level is associated to physical dis-
ease of the vocal cords as is also supported by Wuyts and
allied.41 Other factors than the physical characteristics of
the voice may be the important part in the recurrent palsy,
dysfunctional as well as the control group when persons
generate VHI scores. Thus, there seems not to be a strong
general association between VHI scores and acoustic
parameters in the groups without direct vocal cord disease
as is supported by other investigators.6,27 This is also sup-
ported by the fact that it is often low correlations shown
between physical disease factors and quality of life scores.42
There is a need to further study VHI versus acoustic scores
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at specific disease level, especially including more patients in
order to study degenerative/inflammatory patients.
As shown in the present study at group levels acoustic
voice analyses studied by specific laryngeal diseases reflect
in particular if voice physical pathology is present or not. In
addition to some extent the magnitude of such pathology is
reflected. These analyses may therefore be important as
proxy variables concerning potential treatment effects. This
is presently especially the case with jitter, shimmer and
NHR as supported by Gillespie and allied.43 To study
laryngeal patient acoustic analyses dependent on difference
from controls further will be a future aim in order to study
if the discrepancy power can be used at individual level.
Between various patients presently acoustic analyses only
seems to be most useful at group levels. If new studies are
conducted in a multicenter fashion, one will know more
exact yield of adding acoustic measurements to the diagnos-
tic workup of individual laryngological patients.
CONCLUSIONS
We have shown among larynx disease patients that acoustic
analysis may segregate between in particular patients as
groups with laryngeal cancer, laryngeal degenerative/
inflammatory disease and recurrent palsy, but not dysfunc-
tional disease compared to control conditions. VHI scores
correlate to acoustic scores among laryngeal cancer and
laryngeal degenerative/inflammatory patients. Acoustic
analyses hold the promise to be an importance measure
when diagnosing and treating laryngological disease.
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